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ABSTRACT 
Vascular and Mechanical Changes in Bone in Response to Chronic Ischemia and 
Mechanical Loading  
 
Michael Govea 
 
Peripheral artery disease (PAD) and osteoporosis have recently been shown to 
be associated; with the parallel occurrence suggesting that PAD related ischemia may 
cause or enhance the onset of osteoporosis. In order to determine the mechanism 
linking osteoporosis and PAD this paper will examine the effects of ischemia and 
mechanical stimulation on bone remodeling. An immunohistochemistry protocol for 
vessel marking in bone was also developed. Ischemia was induced in a mouse model 
to determine vascular and mechanical property changes in bone in response to 
hypoxia, and mechanical loading-induced remodeling was analyzed for vascular 
changes. Both ischemia and mechanical loading increased bone vessel density, with 
ischemic bone increases seen at day 7 and 14. Bone stiffness increased after induced 
ischemia at day 28. These results point to resultant hypoxia from ischemia drives 
bone mechanical property changes, likely through stimulation of bone remodeling. 
We also conclude that an increase in vessel density is seen after induced mechanical 
loading of bone. Establishing the vascular contribution to the remodeling process may 
reveal treatment opportunities for remodeling-dependent pathologies such as 
osteoporosis. 
 
Keywords: Ischemia, Induced Remodeling, Angiogenesis, Osteoporosis,  
Peripheral Artery Disease 
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 CHAPTER 1: INTRODUCTION 
 
 Peripheral artery disease (PAD) and osteoporosis, although affecting separate 
organ systems, have recently shown associated and parallel occurrence. The diseases 
share common risk factors [1], including age dependent association [2], and PAD 
occurrence is 5 times greater in women with osteoporosis than women without the 
condition [3]. To understand the relationship between these diseases, this chapter 
provides an overview of the normal vascular and bone remodeling systems, the 
individual disease pathologies, and a discussion of the potential interplay between the 
two systems. 
 
Normal Vascular Function 
 The circulatory system is the most vital component of a multi-cellular 
organism, because it performs the nutrient and waste exchange, including oxygen 
delivery, required to maintain homeostasis [4, 5]. This critical function arises from 
the limited distances molecules can travel via diffusion, such that in a complex 
multicellular organism, convective and diffusive transport effectively contribute to 
the exchange of nutrients and wastes in all cells. This exchange is accomplished with 
a highly branched network [4] that can be divided into arterial and venous sides. The 
arterial side of the vasculature carries oxygenated blood away from the heart (except 
in the case of the pulmonary circuit) and is responsible for flow and pressure 
regulation of the blood supply [4, 5]. The venous side of the vasculature transports 
deoxygenated blood back to the heart and is primarily responsible for the 
1 
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inflammatory response (venules) and function as the blood reservoir [4, 5]. 
Interfacing the two sides of the vascular system are the capillaries, the smallest 
vessels that are the site for nutrient and waste exchange [4, 5]. 
 Within the main vessel classes, arterioles and venules reside in the network as 
a transition between the arteries and capillaries and the capillaries and veins, 
respectively. Arterioles and venules are larger in diameter than the capillaries but 
smaller than their respective main vessels [4, 6, 7]. The network of arterioles, 
capillaries and venules reside within the tissues and comprise what is typically 
referred to as microvasculature. Acting as the functional component of the circulatory 
system, the microvasculature is directly responsible for the nutrient and waste 
exchange at the tissue and cellular level [4, 5]. Characteristics of the 
microvasculature, such as total vessel area, influence flow within a given region. For 
tissues to function properly, delivery of blood must be modulated to match nutrient 
and oxygen delivery with nutrient and oxygen demand [4, 8]. Individual vessel types 
of the microvasculature provide unique contributions to the system’s function. 
The rate of oxygen and nutrient exchange is grossly dependent on the amount 
of blood flowing through a given region. Blood flow regulation is accomplished by 
the arterioles in the microvascular network [4, 6, 7], due to their ability to constrict or 
dilate with the help of smooth muscle cells (SMC), which contract or relax, 
effectively modulating blood flow to a given downstream tissue [4, 5, 8]. In addition 
to blood flow, vessel structure greatly contributes to mass transfer, with capillaries 
having the thinnest walls, a lack of smooth muscle, and small diameter to facilitate 
maximal delivery [4, 5]. Total capillary area and variability in capillary structure 
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within a local microvasculature also contribute to the capacity for mass transfer. 
Lastly, partial pressures dictates oxygen diffusion into tissue; the greater the oxygen 
pressure differential, the greater the gas exchange [4]. Interplay of these 
microvascular components dictates the mass transfer profile within a tissue. 
 Different tissues have unique vascular requirements determined by factors 
such as: pressure gradients, physiologic function, and spatial properties. For example, 
the muscle, kidney and liver have similar spatial and metabolic needs, but due to their 
physiologic functions, capillary structure varies dramatically. SEM images compiled 
in Figure 1 illustrate this eventuality, and highlight the distinct structural differences 
between the vessel networks. Vascular networks in bone are physically constrained 
by the tissue itself, thus are primarily dendritic (stem and leaf branching pattern) [9] 
and the capillary number per arteriole in bone is greater than what is typically seen in 
muscle, as evidenced by a single arteriole feeding a large capillary network in the 
humeral growth plate, for example [9]. Figure 2 illustrates the dendritic vascular 
networks in bone. In addition to nutrient and waste exchange, bone vasculature has a 
large influence on local bone deposition [9]. For example, in fracture repair, 
vasculature invades the tissue void and accompanying osteoclasts degrade any 
cartilage or matrix prior to mineralization in regions adjacent to the invading 
vasculature [9]. 
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Figure 1: Tissue specific microvascular networks. 
The SEM comparisons highlight the distinct morphological differences of the 
vasculature depending on the organ/tissue. White bar is 40 um [10]. 
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Figure 2: Microvasculature in bone. 
Top figure depicts periosteal vasculature with the main arteriole and venule  
marked (Ma and Mv). The bottom figure illustrates vasculature in the subchrondral 
bone, with the C indicating vascular cartilage and the arrows in the  
sub-figure indicating capillary loops. Used with permission [11] 
 
 To account for variability in microvascular needs between tissues, the artery-
arteriole-capillary network configuration can exhibit different arrangements. A 
dendritic, or stem and leaf, network features a main feed vessel branching into two 
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smaller, parallel daughter vessels, followed by those daughter vessels splitting into 
two more smaller vessels, and so on [6, 7, 12]. Many vessel branches, or bifurcations, 
occur before the resulting daughter vessels reach capillary size. All vessels in the 
resultant network are connected in a linear and one directional manner, with each 
vessel pair being fed by only the ‘parent’ vessel upstream with no other flow 
influences [6, 7, 12]. Arcaded networks feature similar bifurcation characteristics, but 
not all vessels are connected in a strictly sequential orientation. The two network 
configurations are illustrated in Figure 3. Anastamoses, the connection between two 
arterioles of the same relative size, are prevalent, and result in many vessels of similar 
diameter running in parallel with each other, affecting flow profiles is downstream 
vessels [12]. These parallel running vessels are termed collaterals and function, 
amongst other things, to maintain a constant blood pressure in the tissue and regulate 
blood flow [4-7, 12]. The uniform tissue flow parameters ensure consistent oxygen 
and nutrient exchange within the tissue. The presence of collaterals facilitates this 
homogenous mass transfer profile, enabling constant fluid parameters and 
maintaining tissue homeostasis. 
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Figure 3: Vessel network arrangements. 
Examples of dendritic (A) and arcaded (B) vessel network arrangements.  
Only illustrating the arterial side of the network fed by one main vessel, 
 with bifurcations and anastomoses marked with red dots. 
 Direction of flow is also indicated by the arrow 
 
In addition to tissue effects, blood flow is also dependent on vessel topology 
because flow is largely dictated by vessel diameter. Network morphology is tied to 
tissue anatomy and physiology, for example, the kidney requires a large network of 
smaller vessels to increase mass transfer. Acutely, flow can be modulated by dilation 
or constriction of vessels, from either a conducted or flow-mediated response 
[13].Chronically flow is altered through structural remodeling, driven by 
environmental or flow-based alterations [12, 14]. An example of structural 
remodeling attributed solely to flow mediated changes is illustrated in Figure 4. The 
most common structural remodeling processes are arteriogenesis and angiogenesis 
and play a vital role in preserving tissue functionality. 
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Figure 4: Depiction of vessel network alterations. 
Flow mediated vascular changes [14]. Am Physiol Soc, used with permission 
 
Arteriogenesis 
 Arteriogenesis is the increase in lumen size in preexisting vessels or 
arterialization of capillaries [15]. An occlusion or obstruction in an artery or arteriole 
will result in reduction of blood flow to distal tissues. Arteriogenesis occurs to 
normalize the increased shear resulting from the occlusion experienced by implicated 
collaterals, through the manipulation of collateral diameter or number, termed 
collateral enlargement or capillary arterialization, respectively [12, 15, 16]. A 
decrease in the blood flow to the impaired tissue will lead to an increased pressure 
drop in the collaterals that circumvent the occlusion. An increased pressure drop leads 
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to an increase in blood flow in these effected collaterals, and subsequently, an 
increase in shear stress [16, 17]. 
 The primary stimulating factor for both forms of arteriogenesis is an increase 
in fluid shear stress (FSS) along the luminal surface of the endothelium [15, 16, 18, 
19]. Elevated FSS causes initial endothelial distress and vasodilation in parallel 
collaterals in response to acute occlusion [8, 17]. Highly arcaded vascular networks 
do not show appreciable loss of perfusion immediately following occlusions due to 
the initial dilatory response, but networks comprised primarily of dendritic vessel 
connections, as in bone, show much greater initial loss of perfusion [12]. The 
presence of collaterals appears to be tissue specific and dependent on VEGF and the 
VEFG-A gene expression [20]. 
 Due to the vessel network configuration and spatial boundaries present in 
bone, capillary arterialization is the most likely mechanism of arteriogenesis to occur. 
In order for enlarged capillaries to undergo arterialization, SMCs must be recruited in 
one of several ways: proliferation or migration of SMC from upstream arterioles, 
pericyte differentiation (as determined by expression of smooth muscle markers, such 
as alpha actin) [12], or fibroblasts migration and subsequent differentiation into a 
smooth muscle phenotype [21]. Platelet derived growth factor (PDGF-B) is 
implicated in arterialization, impacting SMC proliferation [22]. 
Fluid flow alterations, associated wall stresses, and endothelial inflammation 
appear to regulate the arterialization process leading to capillary remodeling [12, 17]. 
Fibroblasts are activated through endothelial cell distress signals caused by increases 
in wall stresses or inflammatory conditions such as oxidative stress [17, 21]. Once 
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sufficient arterialization and/or collateral enlargement has occurred, blood flow 
within each vessel will increase. Due to the increase in blood flow, the initial 
increased pressure gradient subsides resulting in reduction in fluid shear stress, 
signaling the maturation of the vessel/vessel network and arteriogenesis is halted, as 
the stimulus is no longer present [19]. 
Although the vasculature is remodeled in response to the tissue ischemia, the 
original occluded artery is not replaced by a single vessel but by increases in existing 
vessel networks [19]. Not all vessels in the network undergo remodeling and the 
optimal total tissue resistance is not fully reestablished because of the increased 
number of vessels that compensate for the larger occluded artery [19]. Despite this, 
arteriogenesis is a critical response that results in vascular compensation for an 
occlusive event. 
 
Angiogenesis 
Insufficient blood flow, termed ischemia, will result in a diminished capacity 
for oxygen and nutrient delivery. The function of angiogenesis is to alleviate a 
hypoxic environment by network expansion in ischemic tissues [8, 15, 23, 24]. 
Sprouting of new capillaries and splitting of existing capillaries, termed 
intussusception, helps re-establish sufficient oxygen delivery to the tissues [25, 26]. 
Sprouting angiogenesis, defined as creation of new capillaries, commences 
with the activation, or distress, of the local endothelial cells [15]. Hypoxia, or lack of 
oxygen, is the primary stimulus for sprouting angiogenesis which initially results in 
increased permeability and cell proliferation in response to hypoxia [8, 15, 25, 27]. 
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Under normal conditions, oxygen is present in the intracellular environment and binds 
to Hypoxia Inducible Factor (HIF), rendering it ineffective. An unbound HIF 
molecule (in a hypoxic environment) is one of the main perpetrators of the 
angiogenesis and leads to several cellular responses [8, 15, 25, 27] including cytokine 
release and initiation of growth factor production. Fibroblast growth factor (FGF) and 
vascular endothelial growth factor (VEGF), among other molecules, are some of 
HIF’s most relevant downstream transcriptional targets [8, 15]. 
Following increased vessel permeability driven by HIF activated VEGF, 
degradation of the vessel basement membrane and local extracellular matrix (ECM) 
occurs [15, 28]. ECM degradation, through VEGF activation of matrix 
metalloprotienases (MMP), provides a region for vessel growth [15]. Local VEGF 
also triggers endothelial cell proliferation and differentiation in proportion to and in 
accordance with the local VEFG gradient [15, 28]. FGFs induce mitogenic (cellular 
division) qualities as well, and influence chemotactic (cellular movement) properties 
of sprouting cells leading to endothelial migration [23].Cell to cell contacts are 
established with adjacent, proliferating cells [23] facilitated by platelet endothelial 
cell adhesion molecule (PECAM); the main cellular adhesion and signaling protein 
within the endothelium [28]. With continued VEGF and FGF exposure, proliferation 
and migration continue to form a new capillary loop, and interaction with surrounding 
ECM and perivascular cells promotes lumen formation [15]. 
Vessel lumen development is regulated by a host of factors including VEGF 
and occurs through cell reorganization, with the basement membrane reformed by the 
endothelial cells themselves [23, 25]. Pericytes, which are structural cells, assist with 
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lumen formation and endothelial cell guidance during this vessel growth process [23-
25]. Capillary loops form within 5 days of response initiation [24, 25, 28] and 
increase the mass transfer capacity within the local tissue, partially alleviating the 
ischemic environment. 
Intususseception is the splitting of capillaries through pillar formation in the 
vessel lumen [26], stimulated by increases in shear stress [25, 26] that result in 
upregulation of VEGF receptors [28]. Consistent with common angiogenic 
modulators, intussusception requires VEGF and FGF [24, 26, 28]. The 
intussusception process initiates with a collagen pillar forming at either side of the 
lumen and extend from the vessel walls, eventually connecting the opposite sides of 
the capillary. As more pillars form and elongate, facilitated by myofibroblasts, a rift 
in the lumen arises, splitting the capillary into two distinct vessels [25, 26]. This 
angiogenic type does not require much cell proliferation [25, 26], and in adults, 
occurs primarily in pulmonary system, with some prevalence in myocardium and 
skeletal muscle [25]. With intussusception, blood vessels can be formed more rapidly 
than by sprouting [25, 26], by consuming less energy than sprouting [25]. 
 Angiogenesis is vital to the restoration of blood flow to ischemic tissues, 
however, angiogenesis alone cannot fully restore necessary blood flow in a model of 
chronic ischemia [24]. Because the capillaries have little control of how much blood 
is delivered, a robust angiogenic response alone cannot relieve tissue ischemia 
without the contribution of upstream arterioles [29]. 
Tissue damage from vessel occlusion and ischemia is localized, affecting 
primarily the capillary and arteriole networks. Because of this occurrence, one can 
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expect that most vascular changes will arise within the arteriole and capillary domain 
through angiogenesis and arteriogenesis [12]. Knowledge of vessel adaptation will 
help reveal interplay between the vascular other physiological systems. 
 
Normal Bone Remodeling 
Bone provides mechanical structure through two main tissue types: cortical 
and trabecular [5, 30]. Cortical bone is comprised of compact osteons, which form the 
outer layer of the bone and provide the bulk of the strength [5, 30]. Trabecular bone 
resides inside of the cortical bone, aids in load distribution, and is referred to as 
spongy bone because of its porous, matrix structure [5, 30]. Because of its load 
bearing function, bone is regularly remodeled [5, 30] and adapts through targeted 
sculpting of the tissue [31]. Bone structure is optimized for strength with respect to its 
weight, and its trabeculae are approximately aligned with the principal directions of 
applied stress [31, 32], indicating that bone adapts its structure in response to local 
strain [30].  
Bone remodeling involves osteoblasts, osteocytes, and osteoclasts, which 
collaborate in basic multicellular units (BMUs) [32], depicted in Figure 5. 
Osteoblasts are involved in bone formation and synthesis, osteoclasts dissolve and 
resorb damaged or unnecessary bone, and osteocytes are mature osteoblasts that 
become integrated into the mineral matrix of bone and sense mechanical loads [5, 30-
32]. In normal circumstances, the main stimulus for remodeling starts with the 
osteocyte. These cells respond to the local environment and mechanical factors such 
as stretch, pressure, and flow [30]. Sensing of high strain can trigger remodeling, and 
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formation of microcracks will lead to osteocyte apoptosis, a potent remodeling 
stimulator [5, 30-32]. Fatigue loading is the main perpetrator of microcracks, and is 
defined as the occurrence of cracks that propagate in the tissue at lower than fracture 
magnitudes if the load is applied as a cyclic loading and unloading [30]. The 
magnitude of fatigue damage is proportional to bone structure and vascular changes 
that occur during the remodeling process [33].  
 
 
Figure 5: Process of bone remodeling, displaying the main cell types [34] 
 
Microdamage or apoptosis results in osteoclast recruitment to the site of the 
crack or damaged cell [5, 30-32]. The osteoclasts dissolve and remove the damaged 
tissue, which is then replaced with new tissue by osteoblasts [5, 30-32]. Upon mineral 
deposition, osteoblasts become integrated into the boney matrix and mature into 
osteocytes [5, 30-32]. Bone endothelium, in locations of damage or growth, actively 
recruit osteoclasts for either remodeling or vascular expansion [9]. Recruitment is tied 
to the RANK / RANKL complex interaction; RANK is an osteoclast membrane 
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receptor and RANKL is the associated ligand expressed on endothelial cells and 
osteoblasts [9]. Hematopoietic derived osteoclasts and osteoblasts circulate in the 
peripheral vasculature and exist in bone marrow, and while poorly understood, it is 
thought that endothelial cell adhesion relocates them from these two sources into the 
tissue of interest [9]. However, osteoclast extravasation is not required for bone 
removal, evidenced by lower bone mass in non-vascularized tissue compared to 
vascularized tissue [9]. 
Osteoclasts produce heparinase, which releases VEGF from heparin, which is 
bound to the ECM, allowing VEGF to activate the VEFG receptor, subsequently 
increasing expression of the RANKL complex on osteoblasts, and increasing 
expression of RANK on endothelial cells [9, 35]. Local angiogenesis is subsequently 
induced by the activation of RANK, for reasons unknown, contributing to the vessel 
remodeling as the vasculature advances [9, 35]. Only cells adjacent to capillaries give 
rise to bone tissue and eventual mineralization (because of the RANK / RANKL 
interactions between the osteoblasts, osteoclasts, and endothelial cells), therefore 
implicating any surrounding vasculature in the remodeling process [9, 34]. From 
these findings we can deduce that the invading vasculature is a primary factor for 
regulation of the ossification process [9], specifically, VEGF appears to regulate 
osetogenesis and angiogenesis, and is required for bone formation [9]. Thus, 
interaction between both the bone and vascular system dictate normal bone function. 
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Impaired Bone Function: Osteoporosis 
Osteoporosis is generally described as a systemic skeletal disease, 
characterized by deterioration of bone micro-architecture leading to increased bone 
fragility [34, 36]. Specifically, osteoporotic bone contains fewer and narrower 
trabeculae, with a loss of connectivity between individual trabeculae, and decreased 
wall and osteiod (mineralization) thickness attributed to loss in osteocyte density and 
viability [37-39]. Osteoporosis is often an asymptomatic condition prior to a fracture 
event [36] and clinically, osteopenia and osteoporosis are defined by loss of bone 
mass measured in the lumbar spine or hip. Osteopenia and osteoporosis are 1 SD and 
2.5 SD, respectively, below the average bone mass of healthy, thirty-year old and sex-
matched control subject [37]. 
Peak bone mass in humans is seen anywhere from 25 to 30 years of age [37], 
but from that point in time, fracture rate and osteoporosis increase dramatically with 
age [40]. Three to six percent of women have osteoporosis by 50, 50-75% of women 
have osteoporosis by age 90 [40] and there is a 40% risk of major fracture for women 
over 50 [40]. For men, there is a 1% prevalence at age 50 and 15-28% prevalence at 
age 90 [40]. Female osteoporosis is almost exclusively related to menopause, during 
which greatly accelerated bone loss can account for 33% of lifetime bone loss [37]. 
Enhanced bone resorption is the main contributor related to estrogen deficiency, but 
in the years following menopause, lack of bone formation is observed and contributes 
significantly to the disease onset [34]. Furthermore, duration of menopause is more 
important than the age of onset in terms of osteoporosis onset and development, with 
longer menopause leading to increased osteoporosis [36]. Additional risk factors for 
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developing osteoporosis include alcohol use, tobacco use, drug use, inactivity, and 
poverty [41]. 
 Fracture is the primary risk for patients with osteoporosis and there are 1.5 
million osteoporosis related fractures per year in the US [41]. The femoral head is 
particularly susceptible to osteoporosis [38], and hip fracture accounts for 18% of all 
osteoporotic fractures [42]. Osteoporosis and related fractures in the Americas and 
Europe contribute to the loss of 2.8 million disability adjusted life years (DALY) 
[40], which accounts for 1.75% of DALYs for non communicable diseases in western 
society and 0.83% of worldly DALYs [42]. 
Osteoporosis is likely to be caused by a change in the complex interactions 
among regulators of bone cell function [34]. Common cells and molecules involved 
are the osteoclasts, osteocytes, osteoblasts, and estrogen, and in osteoporotic patients, 
osteoblasts have impaired function leading to inadequate bone formation over time 
[34, 39]. More importantly, the osteoclasts seem to be highly activated and 
unregulated in osteoporotic patients [34, 39] resulting in excessive bone resorption, 
decreased bone mass, and microarchitectural deterioration of the skeleton [34]. The 
specific mechanisms are not well identified, but some factors such as estrogen 
deficiency seem to contribute to the increase in systemic osteoclast activation [34, 
36]. Other factors may be chronic glucocorticoid treatments as well as a host of 
cytokines, as they seem to contribute to osteoclast activation and subsequent bone 
resorption [34, 37]. The combination of osteoblast dysfunction along with enhanced 
osteoclast activity leads to the marked loss in bone mineral density [39]. 
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 Due to the prevalence, morbidity and mortality associated with osteoporosis, 
several treatments are currently utilized. Bisphosphonates inactivate osteoclasts [4, 
34], leading to decreased resorption, but also an increase in stiffness and micro-
damage buildup which can have severe long-term complications [4, 34]. Strontium 
renelate (SR), although not currently FDA approved, acts as both an anti-resorption 
and bone forming drug concurrently [43]. SR increases cortical bone thickness in 
osteoporotic patients and induces a more robust trabecular bone network [43]. 
 Treatments thus far have focused primarily on targeting the osteoclasts and 
osteoblasts, but other cellular mechanisms have yet to be targeted. The 
interdependence of the vascular system and bone remodeling process needs to be 
explored further so that new treatment targets can be revealed and utilized. For 
example, by stimulating angiogenesis and vascular remodeling, bone remodeling and 
formation could be stimulated. 
 
Impaired Vascular Function: PAOD 
 Peripheral arterial occlusive disease (PAOD), often referred to as peripheral 
artery disease (PAD), is a major cause of disability and lifestyle changes worldwide 
[44]. The cause of PAD is atherosclerosis in peripheral vessels and is defined by 
ischemia in a patient’s extremities [44]. 
 PAD has about 10% prevalence in the population with increasing occurrence 
in elderly patients [44]. Some estimates number the individuals affected with PAD at 
20 million in the United States [44]. In elderly patients there is a much higher 
occurrence, and onset of acute limb ischemia attributed to PAD is typically related to 
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increased risk of mortality and amputation in the effected limb [29]. Peripheral 
atherosclerosis, which leads to PAD shares common risk factors with coronary artery 
disease including: advanced age, female sex, diabetes, tobacco use, and hypertension 
[17, 44]. Increased mortality has been observed when PAD is diagnosed in 
conjunction with coronary artery disease [44, 45] and additional disease 
comorbidities include chronic arterial disease, hip fracture, lower extremity 
performance (measured by treadmill exercise duration) and decrease in bone marrow 
density (BMD) [1, 17]. 
 Diagnosis of the disease is primarily performed by using the Ankle Brachial 
Index (ABI) which measures the blood pressure ratio between the ankle and arm, 
during both rest and exercise [1, 44, 46]. Typically, symptoms arise when the ABI is 
less than 0.8, with pain and tissue loss occurring at values of <0.5 and <0.3, 
respectively [44]. 
Growth of atherosclerotic plaques can progress gradually, mainly caused by 
an accumulation of oxidized LDL (low density lipoprotein) in the subendothelial 
space [47]. Atherogenesis leading to the development of PAD is a function of 
turbulent flow in conduit arteries and subsequent inflammation of the endothelium 
[47]. Specifically, subendothelial ox-LDL activates macrophages, leading to 
oxidative stress, inflammatory response, plaque formation, and eventual endothelial 
dysfunction. The larger the plaque becomes, the greater the vessel occlusion [47]. 
Development of PAD leads to lower-limb pain with exercise, also known as 
intermittent claudication, and possible critical limb ischemia [17, 45], lower limb pain 
at rest. Disease progression is most often undetected due to the gradual nature of 
20 
disease onset and ordinarily has asymptomatic presentation until reaching a critical 
level [44]. 
Pathophysiology of the disease usually takes on the following characteristics. 
Flow induced collateral dilation occurs in the side stream collaterals near the 
occlusion as an acute response to a developing plaque [17]. Chronic response occurs 
via vascular remodeling, and appears to result in the decrease of collateral resistance 
over time, but distal resistance associated with the microvasculature does not change 
significantly in symptomatic patients [17].  
Often in symptomatic patients, the endogenous vascular compensation 
response is impaired, including lacking the capacity for vasodilation, severely 
diminishing the capacity for repair [45, 48]. Depending on the tissue characteristics, 
remodeling activity will vary. An arcaded vascular network experiences primarily 
arteriogenesis, where as a dendritic network experiences more angiogenesis and some 
arteriogenesis. [12]. In a diseased state unable to compensate, blood flow becomes 
restricted in affected tissues and ischemia will result, leading to inefficient nutrient 
delivery, eventually resulting in a tissue death [8]. 
 
PAOD and Osteoporosis Link 
 A large majority of the research of PAD has been in muscle [8, 12, 15, 16, 24, 
27, 29, 45, 48, 49], leaving implications in bone poorly defined. However, recent 
findings may bridge the gap to bone by relating chronic ischemic disease and 
osteoporosis. High level associations between PAD and hip fracture are explained by 
age, lower bone mineral density (BMD) and poorer lower extremity performance 
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(based on treadmill walking) [1, 35], including direct associations between 
osteoporosis and PAD in women [2]. Risk factors for osteoporosis and atherosclerosis 
overlap; including advanced age, smoking, diabetes, and physical inactivity [1]. 
Furthermore, PAD occurrence is 5 times greater in women with osteoporosis than 
women with normal BMD [3], femoral neck BMD is a predictor of PAD [3], and low 
BMD correlates with calcification of atherosclerotic plaques [50]. 
Osteoprotegerin (OPG), which inhibits RANK mediated osteoclast activation, 
shows increased levels in patients with PAD and may help explain initial 
relationships between the two diseases [34, 50]. Prior discussion revealed that the 
RANKL complex is implicated in local inflammatory bone loss by activation of 
osteoclasts [9, 34]; and that local angiogenesis triggered by activation of RANK 
contributing to vessel remodeling [9, 35]. In the case of osteoporosis, where there is 
an excess of osteoclast activity, OPG production is stimulated by tumor necrosis 
factor as a response to suppress the osteoclast activity, and by endothelial cells as an 
autocrine anti-apoptotic factor [50]. Since there is increased OPG, which disrupts the 
RANK / RANKL interaction, the angiogenesis may not be stimulated, resulting in 
diminished capacity for bone remodeling. This may explain the ischemic and disease 
condition based on bone physiology. 
Vascular necrosis and chronic inflammation correlate to osteoporosis and 
increased resorption through recruitment of osteoclasts to the site of endothelial 
activation [9, 35]. Invading vasculature in bone is responsible for regulation of the 
ossification process and angiogenesis is required for bone regeneration [9]. In a 
patient with PAD the vasculature lacks the ability to acutely dilate or outwardly 
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remodel, diminishing the capacity for structural vessel adaptation [17]. This vascular 
impairment may lead to a diminished capacity for bone repair, thus leading to 
osteoporosis. 
Symptoms associated with PAD, namely intermittent claudication, may also 
contribute to the development of osteoporosis. A patient’s activity will be restricted 
with pain related symptoms, such that normal mechanical stimulus is diminished, 
leading to bone removal associated with remodeling. And if bone resorption is due to 
advanced age or estrogen deficiency, the mechanical integrity of the bone may be 
compromised, leading to osteoporosis. 
Aside from previously described treatments that target osteoporosis alone, 
Vitamin D administration has seen positive results for patients with both PAD and 
osteoporosis [51]. Vitamin D increases BMD in osteoporotic patients with PAD and 
alleviates symptoms associated with lack of vitamin D, including bone aches, pain, 
and weakness [51]. It was hypothesized that due to pain associated with both 
diseases, the patients were less active, resulting in less vitamin D adsorption from the 
sun [51]. This treatment strategy would be effective if the cause of the combined 
disease stemmed from inactivity, as previously suggested. 
 While each hypothesis is plausible, determining the mechanism linking 
osteoporosis and PAD will stem from initial examination of the effects of ischemia on 
bone remodeling. Determining how parameters, such as vessel density and bone 
remodeling, change with ischemia is crucial to understanding the interaction between 
the two diseases. 
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Aims and Hypotheses 
 As the first step to understanding the disease links, the main focus of this 
research is to examine the physiologic responses to ischemia and fatigue loading on 
bone remodeling. Interplay between bone remodeling and vascular remodeling has 
been examined in fracture repair and in induced remodeling [52, 53], but little is 
known regarding the remodeling response to an ischemic environment. Based on the 
void in understanding, and in order to providing a foundation of initial observations, 
the objectives of this thesis are: 
 
1. Establish a protocol for use of immunohistochemistry for identification of 
blood vessels in bone. The goal of this aim was to create a reliable method to 
quantify the vascular changes in bone in response to ischemia and fatigue 
loading. 
2. Determine the effects of ischemia on tibial mechanical properties and 
microvasculature, and examine any time dependence associated with the 
changes. The purpose of this aim was to quantify and correlate changes in 
vasculature in response to induced ischemia. 
3. Determine if increased vasculature will occur in response to mechanical 
fatigue loading, consistent with prior research. The goal of this aim was to 
demonstrate the vessel identification protocol’s effectiveness and to determine 
time dependant changes in the bone vasculature during load-induced 
remodeling. 
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CHAPTER 2: IMPACT OF ISCHEMIA ON VASCULARIZATION AND 
MECHANICAL PROPERTIES IN BONE 
 
Introduction 
Osteoporosis is likely caused by a change in the complex interactions among 
regulators of bone cell function [34]. Treatments thus far have focused primarily on 
regulating osteoclasts and osteoblasts, with limited success, but other cellular 
mechanisms have yet to be targeted. Possible interdependence of the vascular system 
and bone remodeling process needs to be explored further so that new treatment 
targets can be revealed and utilized. There appears to be a correlation between male 
patients with PAD and lower BMD [1], and a direct association between the two 
diseases in elderly women [2]. This parallel disease occurrence suggests that PAD 
related ischemia could cause or enhance the onset of osteoporosis, so in order to test 
this hypothesis, it is necessary to know the direct impact of ischemia on bone. One 
causal explanation is that hypoxia resulting from induced ischemia will result in 
alteration of gene (VEGF, HIF) expression and cell (osteoclasts, endothelial cells) 
activation, directly impacting BMU activity through the microvasculature. This 
change in BMU activity could affect the bone’s mechanical properties and would be 
directly dependent on local vasculature and blood supply. 
As a starting point there are some known relationships between the vascular 
system and bone tissue, but interaction between the two systems is largely 
uncharacterized. Known associations include a linear correlation between total vessel 
area and bone formation [54], and angiogenesis occurring in areas of bone formation, 
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preceding mineralization [52]. The relationship between blood flow and bone 
remodeling has been only slightly defined in a mechanically loaded environment [52]. 
Compared to structural adaptation in muscle, little is known about the 
resulting mechanical or vascular changes attributed to diminished blood flow in bone. 
Previous studies have primarily examined subchrondral bone and the immature 
femoral head to elucidate the pathologic alterations resulting from ischemia [55, 56]. 
four weeks after an ischemic event, the subchrondral bone exhibited significantly 
increased mineralization [55], and hypoxia induced local chrondrocyte death in the 
region of ischemia [56]. Furthermore, revascularization in the subchrondral region 
occurs within 4 weeks of ischemic event, but revascularization of the bone requires 
more time [56]. Although somewhat narrow in scope, these studies have provided 
initial observation of an ischemic environment in bone and lead to the possibility that 
vascular changes precede bone formation and in areas of ischemia. This possible 
relationship is one of the primary aims of the research presented in this chapter. 
As a possible explanation for this relationship between vascularization and 
bone formation, it appears that hypoxia and the hypoxia inducible factor (HIF-1) 
pathway are intimately involved in bone’s response to ischemia [56, 57]. The HIF-1 
pathway is activated in ischemic tissue [56], and consistent with muscle, the HIF and 
vascular endothelial growth factor (VEGF) pathways are upregulated in bone in 
response to hypoxia [57]. Specifically, VEGF and HIF-1 are upregulated in 
osteoblasts in the region of distress, fracture, or hypoxia [57] and early angiogenic 
response in adjacent cartilage is implicated in the revascularization process of bone 
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[56]. Thus, the HIF-1 pathway couples the angiogenic and osteogenic pathways 
during bone modeling and development [56]. 
Since the HIF pathway is active in ischemic regions, and HIF regulates 
angiogenesis, the next step is to determine the extent of angiogenesis. Angiogenesis is 
required for bone regeneration and osteogenesis [33, 57], but additional contributors 
to the angiogenic response have not been examined. PECAM may facilitate 
interactions between angiogenesis and osteogenesis [58], as it has been implicated in 
angiogenesis thru endothelial activation signaling, cellular adhesion and 
extravasation, and is expressed in hematopoietic-derived osteoclasts [58]. For bone 
remodeling PECAM mediates normal osteoclastogenesis by binding the Syk protein 
(which stimulates osteoclast precursor proliferation), regulating its downstream 
effect. The PECAM knock-out mouse lacks the ability to bind Syk, leading to 
unregulated osteoclast precursor proliferation and subsequently, increased 
osteoclastogenesis and bone resorption [58], resulting in a diminished trabecular bone 
volume [58]. For vascularization in the ischemic bone environment, there is an 
upregulation of VEGF and PECAM, indicative of angiogenesis [56]. Thus, PECAM 
appears to influence both bone remodeling, through osteoclast regulation, and 
vascularization in bone. 
These observations and conclusions are not unexpected, as complement 
processes occur in muscle, but these conclusions help to reveal commonalities, 
including HIF and PECAM, between revascularization and re-ossification, indicating 
a need for further research. However, these studies did not examine cortical bone 
changes or vascular alterations in mature bone. Because PAD and osteoporosis onset 
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occurs in developmentally mature individuals, examination of mature bone is much 
more applicable to the disease states. Due to the gap in understanding, one goal of 
this project is to elucidate vascular necrosis and angiogenic changes in cortical bone 
stemming from the response to ischemia. We also examined any mechanical changes 
resulting from ischemia induced revascularization. If there is a vascular remodeling 
response to the ischemic environment, as would be expected, we should see increased 
in vasculature, followed by enhanced mechanical properties. 
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Methods 
Summary 
Chronic ischemia was induced in the mouse by resection of the femoral artery 
vein pair. Forty three C57BL/6 male mice aged 2-3 months were separated in to two 
groups. All animals except for day 0 underwent the ischemia surgery, with one group 
of mice designated to observe mechanical properties, while the second group was 
used for histological assessment. The day 0 animals did not undergo any procedure 
and served as a control time point. Each of these initial treatment groups was further 
sub divided into four time points, Table 1. Depending on the designation, the tibias 
from each animal were excised and prepared for either mechanical testing or 
histology. A 3-Point Bending apparatus was used to elucidate mechanical properties 
and immunohistochemistry (IHC) was employed for determining blood vessel density 
in the cortical bone of the tibia.  
 
Table 1: Experimental design and animal designation. 
Displayed as number of animals per experiment at a given time point and procedure. 
 
Time Point (Days) Histology Mechanical Analysis 
0 4 4 
7 5 4 
14 6 8 
28 6 6 
 
All surgical procedures and animal handling was approved by the Institutional 
Animal Care and Use Committee (IACUC) prior to experiment initiation. 
Additionally, all surgical procedures were preformed in an aseptic environment. Mice 
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were maintained in micro-isolation cages with a twelve hour light/dark cycle and ad 
libitum access to feed and water. 
 
Surgical Model of Chronic Ischemia – Femoral Artery Resection 
Surgeries were performed under a stereomicroscope and animals were 
anesthetized with isoflurane (1.5-2% in O2 at 1ml/min) throughout surgical 
preparation and procedure. The hair on the medial aspect of each hindlimb was 
removed with trimming clippers and depilatory cream, and disinfected with 
chlorohexidine diacetate. Next, the animal was placed supine on a heating pad with a 
rectal-feedback probe maintaining a 35º C temperature, with the animal’s nose in the 
anesthetic mask. An incision was made on the medial aspect of the left hindlimb and 
extended from the abdominal wall to just above the ankle. Connective tissue was 
blunt dissected from the underlying skeletal muscle and skin, and sterile saline was 
used to irrigate the wound. The nerve adjacent to the isolated artery-vein pair was 
separated, being careful not to damage it. The femoral artery-vein (a-v) pair was 
ligated with 6-0 silk suture proximal to the profunda femoris, and the saphenous a-v 
pair was ligated halfway between the knee and ankle. The fat pad and accompanying 
epigastric a-v pair were removed. The profunda femoris was cauterized at the 
bifurcation from femoral a-v pair, and the saphenous vessel pair was cauterized just 
distal to the ligation. Minor vessel branches from the main a-v pair were cauterized 
prior to resecting the a-v pair away from the host tissue starting at the distal ligation 
and terminating just distal to the proximal ligation. A depiction of the operation and 
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region of vessel removal is displayed in Figure 6. The incision was closed using 7.0 
polypropylene suture. 
 
 
Figure 6: Depiction of resection surgery.  
Region of vessel removed from the medial aspect of the left hindlimb. Dashed line 
corresponds to the portion of vessel excised to induce the ischemic condition. 
 
A contralateral sham surgery involved an incision of equivalent length and 
location on the medial aspect of the right hindlimb, and blunt dissection of connective 
tissue, just as in the previous limb. This sham procedure served as an internal control 
for any effects of general surgical trauma. A subcutaneous injection of the analgesic 
buprenorphine (0.075mg/kg) was delivered following the procedure and the animal 
was allowed to recover until ambulatory in a heated chamber. A detailed surgical 
protocol is reproduced in Appendix A. 
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Tibial Excision and Preparation 
At the assigned time point, the animals were euthanized by cervical 
dislocation and both tibae were excised. Two methods were employed depending on 
the continued use of the tibia. For mechanical characterization, an incision was made 
in the medial aspect of the hindlimb and was extended the full length of the hindlimb. 
The skin was separated and cut away from the underlying muscle from the proximal 
end of the femur to the heel, exposing the distal tendons. All of the tendons were cut 
at the ankle; the patellar tendon was also cut. All surrounding musculature around the 
tibia and fibula was peeled off the bone and removed. The ankle and knee joints were 
severed and the fibula was removed before the now isolated tibia was wiped clean of 
any remaining tissue with a Kimwipe (Kimberly-Clark, Neenah, WI). Appendix A 
details the full protocol. The excised tibae were then frozen at -20ºC for 
approximately 72 hours before thawing and mechanically testing. 
For histological experiments the tibia was excised in a similar manner. The 
skin was removed and the patellar and ankle inserting tendons were cut, however, 
only the gastrocnemius muscle was removed from the tibia and the fibula was left 
intact as well. These two modifications provided better support during sectioning and 
allowed for preservation of the periosteum [52]. Appendix A details the full protocol. 
Once isolated, the tibias were immersion fixed in Histochoice (Electron Microscopy 
Sciences, Hatfield, PA) for 48 hours. Samples were then decalcified for a minimum 
of 5 days in EDTA (Sigma-Aldrich, St. Louis, MO) prior to processing and 
embedding. The day 14 and 28 samples were washed and stored in phosphate 
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buffered solution (PBS) following decalcification in EDTA until the samples were 
processed and embedded. 
 
Mechanical Property Testing 
A servo controlled, 3-point bending apparatus was utilized to quantify the 
material and mechanical properties of the tibia. Due mainly to length constraints, a 3 
point apparatus instead of a 4 point apparatus, which provides more uniform loading, 
was used [59]. Prior to placement into the testing tray, the tibae were thawed and 
moistened with PBS. The bones were positioned with the anterior surface of the tibia 
face down so that when the specimen is viewed at eye level the bone is in a concave 
orientation; this orientation prevented movement of the tibia during the test, which 
was a problem with the convex orientation. The two lower supports of the tray were 
10mm apart and the third ‘point’ was brought down equidistant from each of the 
lower two points to apply a load. The bones were tested in an anterior-posterior 
orientation with the former face down. A load cell (500N, Applied Measurements 
LTD, UK) was attached to the descending arm and force-displacement data was 
gathered at 685Hz. The maximum displacement allowed after contact with the bone 
was 1mm, with the actuator moving at 2mm/min, as per the guidelines put forth by 
the testing protocol. The 1mm maximum displacement sufficiently captures the 
fracture event, without recording superfluous data after the fracture. The apparatus 
and set up is displayed in Appendix B. 
At the conclusion of the test the outside and inside diameters were measured 
at the point of fracture. The measuring apparatus is depicted in Appendix B. Along 
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with equations described by Jamsa [60], detailed in Table 1, the Ultimate load (N), 
Ultimate stress (Pa), Elastic modulus (Pa) and stiffness (N/mm) were obtained.  
 
Table 2: Equations used for Mechanical Property Characterization [60] 
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Immunohistochemistry 
Identification of vessels was performed by staining an endothelial-specific 
glycoprotein with GS-1 Lectin. Following the fixation and decalcification, the bones 
were cut in half transversely at the midshaft, dehydrated, and impregnated with 
paraffin wax in an automated processor before embedding in paraffin wax. Using a 
RM 2255 (Leica Microsystems, Buffalo Grove, IL) microtome, 6 µm sections were 
cut from the blocks starting at the midshaft. The sections were mounted on Super Up 
Rite – Bond Rite slides (ThermoFisher Scientific, Houston, TX) and incubated at 
80˚C for ten minutes. After a xylene wash and a graded ethanol rehydration series, 
antigen retrieval was performed using citrate buffer (RICCA Chemical Co., 
Arlington, TX) at 95˚C for 10 minutes. Treated slides were washed in PBS for 20 
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minutes before 1 hour incubation of Biotinylated GS Lectin I at 10µg/ml (Vector 
Labs, Burlingame, CA). Vectastain AB enzyme (Vector Labs, Burlingame, CA), 
prepared in accordance with the manufacturer’s directions, was applied for a 30 
minute incubation. After a PBS wash, the slides were developed with peroxidase and 
DAB substrate kit (SCBT, Santa Cruz, CA) for 15 minutes. Half of the samples were 
counterstained with 0.5% Methyl Green (Fisher Scientific, Houston, TX). A final 
distilled water rinse, and ethanol and zylene dehydration were executed before 
coverslip application. Appendix A details the full protocol. 
Finished samples were imaged using bright field microscopy (Olympus, 
Center Valley, PA) and a Retiga Exi camera (Q Imaging, BC, Canada). Vessel 
densities as a percentage of the total tibial area were determined with the use of 
Image J (NIH, Bethesda, MD).  
 
SpO2 Measurements 
The induction of an ischemic environment in the hindlimb as a result of the 
surgical intervention was validated using a pulse oximeter (Mouse STAT, Kent 
Scientific, Torrington, CT). Additionally, time to reperfusion following the resection 
procedure was of interest, and the SpO2 measurements quantify the degree of 
reperfusion. For all measurements, the ‘cuff’ was placed around the arch of the 
hindpaw. Hindlimb pulse oxygenation was recorded prior to the resection surgery, 
immediately after the resection surgery, and just prior to euthanizing the animal at the 
prescribed time point for tibial excision.  
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Statistical Analysis 
A two way ANOVA was used to identify statistical differences. If applicable, 
comparisons were made between the operated and sham tibia, using a Student’s t – 
test, and comparisons were made between time points and bone regions using one 
way ANOVA. Some of the figures display percent change data, which was 
normalized by the averaged day 0 data. Results are expressed as mean ± SE. 
Statistical significance was set p < 0.05, unless otherwise stated. 
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Results 
Induction of Ischemia 
 Hindpaw oxygen tensions were not different between the two hindlimbs prior 
to surgery, but levels were significantly diminished in the operated hindlimb 
immediately following the procedure, Figure 7. Based on the significant decrease in 
SpO2 in the distal hindlimb, it can be concluded that ischemia was indeed induced by 
the surgery. Comparison of the operated hindlimbs before and after the procedure 
revealed a post surgical decrease in SpO2 levels, furthering the notion of an induced 
ischemic environment. Interestingly, the unoperated hindlimb showed an increase in 
SpO2 levels following the surgery (P < 0.001). 
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Figure 7: %SpO2 in the hindlimb prior to and immediately following surgery. 
Black bar is contralateral sham and Grey bar is operated hindlimb.  
* p < .05 vs. sham. ‘a’ p < .001 vs. pre-surgical 
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 Reperfusion of the ischemic hindlimb appeared to have occurred prior to day 
7, as no differences were observed between time point specific operated and non-
operated hindlmbs, and there were no differences between the three time points (p = 
0.206), Figure 8. 
 
 
Figure 8: %SpO2 in hindlimb at each time point following induced ischemia. 
 Black bar is contralateral sham and Grey bar is operated hindlimb. 
 
Mechanical Properties 
In accordance with the hypothesis, the thought is that mechanical property 
changes will give insight into the degree of bone remodeling and modeling occurring. 
Quantification of mechanical properties is presented as a way to test the hypothesis. 
Tibial stiffness was not significantly different from the contralateral sham at 
day 7 or day 14, but stiffness was increased at day 28, Figure 10. However, there was 
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no change in stiffness between time points before or following the ischemic event. 
Interestingly, day 0 and day 28 sham stiffness was significantly lower than day 7. 
 
 
Figure 9: Force – Displacement curve from 3 point bend test. 
Linear portion of trace, used for stiffness calculation, and  
ultimate load point is clearly visible as the peak in the trace. 
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Figure 10: Tibia stiffness by time point. 
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is  
operated hindlimb. * = p < .05 vs. sham at Day 28. ‘a’ = p < .05 vs. Day 7 sham. 
 
 The ultimate load data showed similar findings associated with the tibial 
stiffness. There was not a significant increase in the resected compared to sham at any 
time point, but there was trending towards statistical significance for the resected data 
at day 28 (p = 0.061 with 57% Power), Figure 11. However, there were not any 
significant differences between the ischemic time points. Additionally, unlike the 
stiffness data, there were no differences between the sham time points.  
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Figure 11: Ultimate Load by time point. 
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is  
operated hindlimb. 
 
Ultimate stress and modulus were not different between time points or 
between the ischemic and non-ischemic tibae (data in Appendix C). 
The systemic changes in bone mass were quantified with cross-sectional 
cortical thickness measurements at the site of fracture. Figure 12 depicts the field of 
view used to obtain measurements. No differences were seen in the data, and there 
were no differences between time points for either the resected or sham groups, 
Figures 13. 
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Figure 12: Microscope field of view for thickness measurement. 
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Figure 13: Cortical Thickness at each time point. 
Black bar is contralateral sham and Grey bar is operated hindlimb. 
 
 Quantification and correlation of bone mass characteristics with the 
mechanical data were analyzed with cross-sectional area. There was a significant 
increase at day 14 compared to sham, however, the sham data was significantly 
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decreased at day 14 compared to day 7, Figure 14. No differences were observed 
across the resected time points using a one-way ANOVA (P = 0.3). 
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Figure 14 : Cross sectional bone tissue area, by duration after surgery. 
Black bar is contralateral sham and Grey bar is operated hindlimb. 
* p < .01 vs. sham. # p < .05 between Day 7 and 14 sham data points. 
 
 
Histological Analysis 
 Analysis of tibial cross sections encompassed quantification of several 
parameters including regional bone area and cortical vessel number. Vessel densities 
were calculated as the number of positively marked vessels per square millimeter in 
the photomicrographs. Figure 15 illustrates positively marked vessels in cortical bone 
of the tibia. 
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Figure 15: Positive and control vessel marking in cortical bone. 
10x region overview (A, D) with dashed box indicating region of magnification. 40x 
view (B, C, E, F) of specified region. Positively stained vessels are marked with 
white, closed, arrows (B,E). The respective serial controls (no primary antibody) are 
marked with black, open, arrows (C, F). The image on the left depicts vessels of a 
Day 14 resected tibia and the right image illustrates vessels in a Day 28 resected tibia.  
Grey scale bar is 150 µm and black scale bar is 50 µm. 
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 Vessel density increased at day 14 compared to sham, and both day 14 and 28 
were significantly increased compared to day 7 and day 0, Figure 16. There were no 
differences between time points for the sham data points. 
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Figure 16: Vessel density by time point. 
Day 0 is un-operated control. Black bar is contralateral sham and Grey bar is  
operated hindlimb. * = p < .05 vs. sham at Day 28. Both ‘a’ points are  
significantly different from both ‘b’ points and vice versa p < .01. 
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Discussion 
 The majority of the conclusions will be discussed in detail in Chapter 4 with 
this section serving as an overview of findings. The data in Figure 10 suggest that 
there may be bone modeling in the sham tibia by day 7, evidenced by the significant 
increase in stiffness. Furthermore, the data suggest bone removal and/or remodeling 
is occurring in the sham hindlimb by day 28, as the stiffness returns to a pre-surgical 
level. 
 For the ischemic hindlimb, it seems that remodeling is occurring in response 
to ischemia, evidenced by the increase in stiffness at day 28 and the trending of the 
ultimate load data. It appears that the ischemia alone is triggering the remodeling, 
most likely through angiogenesis, substantiated by Figure 16. In response to the 
induced ischemia there is a marked increase in vascular density in the bone by day 14 
and that increase from the day 0 and day 7 baseline is sustained until day 28. 
Interestingly, the most significant increase in vasculature occurs at day 14, prior to 
any observed mechanical changes. Because of this, it appears that the vascular 
response is driving the mechanical and remodeling response, such that an increase in 
vasculature, resulting from the ischemia, is directly affecting bone remodeling. 
Although similar interpretations have been made for bone modeling in fracture repair, 
this is the first examination of direct ischemia effects. 
The vasculature is required for bone remodeling, but the seemingly direct 
connection of the ischemic environment to stimulated remodeling is a novel 
observation. Furthermore, it appears that angiogenesis is sufficient for bone 
remodeling and this ischemic influence on bone remodeling could further our 
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understanding of the system interactions. Thus, the stimulation of angiogenesis alone 
could have an effect on bone, providing new treatment strategies for patients with 
both PAD and osteoporosis. 
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CHAPTER 3: IMPACT OF INDUCED BONE REMODELING ON 
VASCULARIZATION 
 
Introduction 
 Osteoporosis is generally described as a systemic skeletal disease, 
characterized by deterioration of bone micro-architecture leading to increased bone 
fragility [34, 36]. Specifically, osteoporotic bone contains fewer and narrower 
trabeculae, attributed to loss in osteocyte density and viability [37-39]. Fracture is the 
primary risk for patients with osteoporosis and there are 1.5 million fractures per year 
in the US [41]. Osteoporosis and related fractures in the Americas and Europe 
contribute to the loss of 2.8 million disability adjusted life years (DALY) [40], which 
accounts for 1.75% of DALYs for non communicable diseases in western society and 
0.83% of worldly DALYs [42]. Based on the disease prevalence and lack of robust 
treatment options, osteoporosis is an important area of research. 
Osteoporosis is likely to be caused by a change in the complex interactions 
among the regulators of bone cell function [34]. Normally, bone experiences 
microdamage from physiologic loading and adapts through targeted sculpting of the 
bone tissue [31]. This repair and shaping of bone is executed by the basic 
multicellular units (BMUs), composed of osteoclasts that remove tissue and 
osteoblasts that deposit tissue into the tissue void [31]. A remodeling event 
commences when osteocytes (mature osteoblasts) experience elevated or diminished 
loads and undergo apoptosis, a potent bone remodeling stimulus [31]. The integration 
of these three cell types, along with intracellular signaling drives the remodeling of 
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bone. In a patient with osteoporosis, the cellular interactions are altered, resulting in 
an increase in bone removal that is unmatched with bone deposition. Tissue removal 
is the first part of the remodeling process [61], and with inadequate bone deposition, 
the bone loses structural integrity. From this information, we can conclude that 
osteoporosis is intimately related to the bone remodeling process. 
 Greater understanding of the pathophysiology of osteoporosis requires greater 
comprehension of basic bone remodeling and further knowledge regarding these 
processes may provide insight into new treatment targets and for osteoporosis 
treatment. In both fracture repair and mechanical loading experimental models, the 
physiologic response is heavily influenced by bone modeling, remodeling, and 
vascular growth processes, which is why remodeling regulation is studied in these 
contexts. In fracture repair models, vasculature invades the void caused by the 
fracture and accompanying osteoclasts degrade any local cartilage or matrix [9]. 
Vascular changes precede bone formation [33], thus, angiogenesis must occur and, in 
fact, angiogenesis is necessary for the first stage of fracture healing [33, 62]. As the 
vasculature advances into the region of repair, for reasons unknown, angiogenesis can 
be aided by osteoblasts stimulated by a load ‘shock wave’ that results in indirect 
production of VEGF and contributes to local angiogenesis [9]. Callus deposition, 
which is a bony formation comprised mainly of woven bone, is prevalent in these 
types of fracture repair models [53]. It appears that the woven bone does not undergo 
classical bone remodeling, and merely acts as a 'splint' while cortical bone modeling 
and remodeling transpires in the region of fracture [53]. Additionally, the woven bone 
response provides the majority of the structural integrity during the post fracture 
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repair [53]. Although not directly tied to osteoporosis, fracture repair research reveals 
basic interactions between the vascular growth and remodeling pathways, which may 
lead to further understanding of the physiologic deficiencies seen in osteoporotic 
bone. 
Because osteoporosis is dependent on remodeling, examination of only the 
remodeling response is most closely relatable to the disease. The way to assess 
normal, physiologic bone modeling and remodeling is through stimulation of bone 
using mechanical loading. Mechanical loading is utilized to propagate bone 
microdamage, which induces bone remodeling, even in mice, which don’t undergo 
regular remodeling under normal conditions. This practice is well defined [32, 33, 52, 
53, 63] and alters the interstitial shear stress experienced by osteocytes, driving 
osteoblast and osteoclast activity based on the amplitude of stress and any resultant 
osteocyte apoptosis [32], and thus, mechanical stimulation is sufficient for BMU 
associated remodeling [32]. Additionally, the protein periostin, expressed in 
osteoblast precursors, becomes upregulated with increases in applied mechanical 
stress and regulates osteoblast differentiation and adhesion, which is necessary for 
new bone formation [64]. 
A variety of outcomes have been observed as a result of mechanical loading, 
including a significant increase in periosteal woven bone [53] and the role of 
trabecular bone in microdamage propagation. The trabecular bone is a porous 
structure comprised of both rod and plate-like elements [65], with an anatomical 
depiction of these structures shown in Figure 17. Longitudinal rod density appears to 
determine the propensity for induced microdamage, even though these structures 
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account for only a small fraction of the total tissue [65]. Since microdamage is a very 
robust stimulation for bone remodeling, induction of microdamage is a critical 
outcome of mechanical loading. Typical axial loading results in one directional 
deformation, but in transverse loading, trabeculae bending occurs [66]; which seems 
to be a likely method for microcrack development [65, 66]. Coupled with the finding 
that remodeling events transpire in the direction of loading [32] and remodeling is 
proportional to fatigue damage [33], the magnitude of bone formation and remodeling 
can be modulated based on the apparatus and associated loading parameters. 
 
 
Figure 17: Trabecular bone representation. 
Rod elements are shaded and plate elements are opaque [67]. 
 
 Compared to fracture healing, little is known regarding the contribution of 
vascularization and specific cellular remodeling interactions (between osteoclasts and 
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endothelial cells, for example) in response to loading. Previous macro scale 
observations regarding the interaction of bone modeling, remodeling, and 
vascularization include: magnitude of fatigue damage is proportional to vascular 
changes [33] and vascular increases (number and area) are correlated with fatigue 
magnitude [52]. Vessel size and number also increase with loading and appear to 
occur in areas of bone formation, with a maximum occurring 2mm distal from the 
midshaft of the tibia [52]. From a chronological perspective, vascular alteration 
occurs before bone deposition, with the vasculature providing a spatial template for 
loading associated bone formation [52]. These findings have mostly focused on bone 
modeling, but research solely regarding remodeling events is novel. Since much can 
still be learned regarding remodeling, opportunities for research are numerous. By 
characterizing the normal bone remodeling response, possible osteoporosis treatment 
targets can be realized. Progressing from these ideas, this study hopes to visualize and 
quantify vascular changes in the cortical and periosteal bone in response to axial 
loading and subsequent bone remodeling. Spatial and loading duration considerations 
will also be included to further understand interplay between the vascular system and 
bone remodeling in hopes of better understanding the normal bone remodeling 
process. 
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Methods 
Summary 
Bone remodeling was induced in a mouse model by axially loading the tibia in 
a cyclic manner. To determine the vascular response to physiologic loading animals 
were subject to either 2 weeks or 5 weeks of loading. Tibae were excised following 
the determined loading duration and were analyzed for vessel density in the cortical 
and any newly formed bone using IHC.  
All procedures were approved and conducted in accordance to IACUC 
guidelines. Six month old mice were maintained in micro-isolation cages with a 
twelve hour light/dark cycle ad libitum access to feed and water. 
 
Mechanical Loading 1 
Animals were anesthetized with isoflurane (1.5-2% in O2 at 1ml/min) 
throughout the loading procedure. Once the animal was at an appropriate plane of 
anesthetic, it was placed supine on a custom platform within an EnduraTEC Elf3220 
(Bose, Framingham, MA), with its left heel stabilized in a fixed location. A small 
fixture attached to the load cell was then lowered onto the proximal head of the 
vertically oriented tibia, until a preload of .2N was established to prevent movement 
during the procedure. The cyclic loading cycle was run with the following 
parameters: sinusoidal waveform, 1200 cycles at 4 Hz and an applied load range of 1 
to 3.2 N. The right hindlimb of the animal was left unloaded to serve as the 
contralateral control. Each animal was loaded for 5 consecutive days followed by two 
1: Mechanical Loading Procedure was performed by Josiah Kessler 
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days of rest per week. The animals were loaded for either 2 weeks (n = 3) or 5 weeks 
(n = 6). 
 
Tibial Excision and Preparation 
At the conclusion of the prescribed loading duration, the animals were 
euthanized by cervical dislocation and both tibae excised. An incision was made in 
the medial aspect of the hindlimb and was extended the full length of the hindlimb. 
The skin was separated and cut away from the underlying muscle from the proximal 
end of the femur to the heel, exposing the distal tendons. All of the tendons were cut 
at the ankle; the patellar tendon was also cut. Only the gastrocnemius muscle was 
removed from the tibial segment in order to provide better support upon sectioning 
and for preservation of the periosteum [52]. The ankle and knee joints were severed, 
and once isolated, the tibias were immersion fixed in Histachoice (Electron 
Microscopy Sciences, Hatfield, PA) for 48 hours. Samples were then decalcified for a 
minimum of 5 days in EDTA (Sigma-Aldrich, St. Louis, MO) prior to processing and 
embedding. 
 
Immunohistochemistry 
Identification of vessels was performed by staining an endothelial-specific 
glycoprotein with GS-1 Lectin. Following the fixation and decalcification detailed 
previously, the bones were cut in half transversely at the midshaft, dehydrated, and 
impregnated with paraffin wax in an automated processor before embedding in 
paraffin wax. Using a RM 2255 (Leica Microsystems, Buffalo Grove, IL) microtome, 
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6 µm sections were cut from the blocks starting at the midshaft. The sections were 
mounted on Super Up Rite – Bond Rite slides (ThermoFisher Scientific, Houston, 
TX) and incubated at 80˚C for ten minutes. After a xylene wash and a graded ethanol 
rehydration series, antigen retrieval was performed using citrate buffer (RICCA 
Chemical Co., Arlington, TX) at 95˚C for 10 minutes. Treated slides were washed in 
PBS for 20 minutes before 1 hour incubation of Biotinylated GS Lectin I at 10µg/ml 
(Vector Labs, Burlingame, CA). Vectastain AB enzyme (Vector Labs, Burlingame, 
CA), prepared in accordance with the manufacturer’s directions, was applied for a 30 
minute incubation. After a PBS wash, the slides were developed with peroxidase and 
DAB substrate kit (SCBT, Santa Cruz, CA) for 15 minutes. Half of the samples were 
counterstained with 0.5% Methyl Green (Fisher Scientific, Houston, TX). A final 
distilled water rinse, and ethanol and zylene dehydration were executed before 
coverslip application. Appendix A details the full protocol. 
Finished samples were imaged using bright field microscopy (Olympus, 
Center Valley, PA) and a Retiga Exi camera (Q Imaging, BC, Canada). Cross-
sectional area and circumferential measurements were made for each of the zones 
illustrated in Figure 18 based on sample images. Vessel densities as a percentage of 
the total tibial area were determined with the use of Image J (NIH, Bethesda, MD).  
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Figure 18: Tibia cross sections illustrating the regions of analysis. 
Two examples of tissue sections divided by anatomical position for  
regional quantification of vessel densities 
 
Statistical Analysis 
A two way ANOVA was used to identify statistical differences. If applicable, 
comparisons were made between the loaded and non loaded leg, using a Student’s t – 
test, and comparisons were made between loading duration time points and bone 
regions using one way ANOVA analysis. Results are expressed as mean ± SE. 
Statistical significance was set p < 0.05, unless otherwise stated. 
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Results 
 Quantification of parameters including: regional bone area, regional and cross 
sectional circumference, periosteal vessel number, and intracortical vessel number 
will provide insight to the degree of vascular remodeling in relation to bone structure 
changes. Vessel densities were calculated as the number of positively marked vessels 
per square millimeter in the photomicrographs. Figure 19 illustrates positively 
marked vessels in both the intracortical and periosteal regions of the tibia. 
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Figure 19: Positive and control vessel marking, intracortical bone and 
periosteum. 
10x region overview (A, D) with dashed box indicating region of magnification (both 
cortical and periosteal tissue is captured in all images). 40x view (B, C, E, F) of 
specified region. Positively stained cortical vessels are marked with white, closed, 
arrows and positively stained periosteal vessels are marked with black, open, arrows 
(B, E). The respective serial controls (no primary antibody) are marked in a similar 
fashion (C, F). The image on the left depicts vessels of a 2 week loaded tibia and the 
right image illustrates vessels in a 5 week loaded tibia.  
Black scale bar is 150 µm and white scale bar is 50 µm. 
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 Vessel density was significantly increased in the two-week loaded tibae 
compared to the contralateral control and 5-week loaded tibae, Figure 20. 
 
 
Figure 20: Total vessel density for both 2 and 5 week loading cycles. 
Black bar is control tibia, Grey bar is loaded tibia. 
* p < .05 vs. control, # p < .05 vs. experimental time points. 
 
 Analyzing only vessels within the intracortical bone, vessel density is 
significantly increased compared to control at 2 weeks, but not at 5 weeks. 
Additionally, the 5 week control vessel density is significantly greater than the 2 
week control density, Figure 21. Furthermore, the 2-week intracortical vessel density 
ratio is significantly increased compared to the 5-week vessel density ratio, Figure 
22. The ratio was calculated as the loaded tibia vessel density over the control tibia 
vessel density.  
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Figure 21: Intracortical vessel density for both 2 and 5 week loading cycle 
Black bar is control tibia, Grey bar is loaded tibia. 
* p < .01 vs. control. # p < .05 vs. 2 week control 
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Figure 22: Intracortical vessel density ratio for 2 and 5 week loading cycles. 
Ratio is Loaded density / Control density. 
* p < .01 vs. control. 
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 Though differences were observed for total cortical bone vessel density, no 
such conclusions were supported for periosteal density, calculated as the number of 
vessels within the periosteal region per circumferential length, Figure 22, 
 
 
Figure 23: Periosteal vessel density for both 2 and 5 week loading cycles. 
Black bar is control tibia, Grey bar is loaded tibia. 
 
 Regional analysis of the tibial cross sections revealed only one difference; 
after 2 weeks of loading there was a significant increase in the total lateral vessel 
density, Figure 23. It seems that the large difference seen in the lateral region is 
greatly affecting the results regarding total tissue characteristics. 
For a majority of the time points the standard error is quite large, due to the 
fact that some samples within a time point and specific area did not exhibit positive 
staining. Interestingly, the control, 2 week, medial data point did not have any 
positive staining in the data set, reflected in the figure. 
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Figure 24: Regional vessel density for both 2 and 5 week loading cycles. 
Black bar is control tibia, Grey bar is loaded tibia. 
* p < .05 vs. control. 
 
62 
Discussion 
 The majority of the conclusions will be discussed in detail in Chapter 4 with 
this section serving as an overview of findings. The histological data points to a time 
and location dependence for changes in vascular density in mechanically loaded 
tibiae. It appears that at 2 weeks of mechanical loading, there are regional, 
intracortical and total increases in vessel density. Additionally, observed differences 
compared to control at 2 weeks are no longer seen at the 5 week loading time point. 
These two observations can be explained simultaneously with a few key findings. As 
discussed previously, bone overuse leads to increased bone remodeling [61]. It has 
been demonstrated that the initial loading stimulus, rather than the long-term 
stimulus, has a greater impact on bone formation and remodeling [61]. A reasonable 
explanation for the dependence of bone formation on initial loading stimulus, and 
why changes are observed at two weeks and not at five week, are 'desensitization' of 
bone cells occurring with increased loading durations, evidenced by a bone formation 
plateau [61]. Through cytoskeletal reorganization within the osteocyte due to routine 
loading, the mechanosensitivity and activation threshold is altered, resulting in 
diminished bone formation and remodeling over time [61]. If there is a correlation 
between vascularization and bone formation/ remodeling, Figure 20 would support 
the desensitization hypothesis. 
 Figures 21 and 23 reveal regional and intracortical differences in vascular 
densities. Lateral changes are explained by high levels of local strain and previous 
research has shown increased matrix mineralization in the lateral region in response 
to mechanical loading [68]. And consistent with prior conclusions, these changes are 
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only observed at the 2 week loading time point. Interpretation of the intracortical 
vessel density changes may prove to be much more meaningful. Bone modeling 
occurs in the periosteal region with mechanical loading [53], so one can hypothesize 
that remodeling is the primary process occurring in the intracortical bone, as there are 
few modeling events in mature bones in the intracortical region. With this 
assumption, and the fact that vasculature is required for bone remodeling, the increase 
in intracortical vessel density at 2 weeks appears to be indicative of remodeling 
events. If that is indeed the case, it seems that the apparent remodeling profile is time 
and somewhat location dependent. Extrapolating to osteoporosis, if the vasculature is 
intimately involved with the normal remodeling response, this interaction and time 
dependence could be targeted as a possible treatment target or diagnostic.  
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CHAPTER 4: DISCUSSION 
 
The governing objective of this study was to determine the role of the vascular 
system in the context of bone remodeling induced by mechanical loading and 
ischemia. Understanding the vascular role in the bone remodeling and modeling 
processes may reveal treatment strategies for patients with osteoporosis and 
concurrent PAD. The aims of the thesis listed below will guide the discussion. 
1 Establish an immunohistochemistry protocol to identify blood vessels in bone. 
2 Determine the effects of ischemia on tibial mechanical properties and 
microvasculature, and examine any time course of the changes. 
3 Determine if vascularization will occur in response to mechanical fatigue 
loading, consistent with prior research. 
 
Aim 1: Immunohistochemistry Protocol Development 
Overview 
 Most conventional vascular quantification methods used in muscle (ink fill, 
polymer casting, side stream imaging, whole mount imaging, and laser Doppler) are 
not feasible in bone due to tissue location and/or structure, namely, the anatomically 
deep and calcified nature of the tissue. Because of this, little work has been done 
regarding blood vessel quantification in bone in the context of remodeling. 
Immunohistochemistry (IHC) was used to circumvent some of the bone specific 
imaging restrictions present with whole mount and in vivo procedures. The IHC 
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protocol aimed to provide replicable and consistent vessel quantification utilizing 
basic histological techniques. 
 Of the few prior studies that used IHC in bone, all but one examined staining 
bone marrow, and in one instance, a VEGF-A antibody was used as a spatial 
quantification stain in trabecular bone. Other studies have also done some ink 
fill/polymer casting, but the published procedures were not well replicated in the local 
lab setting. Based on the apparent lack of publications using IHC, its use for cortical 
bone staining is uncommon, and this appears to be the first time that Lectin has been 
used in this specific application. 
Biotinylated GS Lectin I was utilized in the protocol after a PECAM antibody 
failed to yield any positive staining. The Lectin used is highly targeted, attaching to 
an endothelial-specific glycoprotein. 
Some challenges arose due to the lack of prior information regarding Lectin 
IHC in cortical bone. Tissue section integrity reduced sample efficiency due to the 
heat antigen retrieval and bone-tissue slide adhesion. Additionally, some bone tissue 
degradation may have occurred in the day 14 and 28 samples that underwent an extra 
PBS rinse prior to tissue processing. This possibility may help explain the results 
observed in Figure 14, where the bone crosssectional area was diminished at day 14 
compared to other time points. Peroxidase incubation times were highly sensitive and 
were subsequently optimized to provide sufficient positive staining without 
sacrificing image clarity and positive contrast. Because the protocol using Lectin was 
new, the resolution of the stain was not very high, most likely staining fewer vessels 
than were actually present in the tissue, compared to other published vascular data 
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[52]. Furthermore, counterstaining of the sections using Methyl Green, Hematoxilyn, 
and Eaosin did not provide improved contrast and identification of positively marked 
vessels. 
Despite these impingements, the protocol adequately met its goals and 
provided quality stains for imaging and analysis. The success of the protocol is best 
illustrated by Figures 15 and 19, which highlight the contrast between positively 
stained vessels and their serial controls (no Lectin applied). 
 
Future Work and Improvements 
 Although the protocol was repeatable and fairly efficient, additional 
troubleshooting and optimization could be performed to increase the efficiency. Aside 
from increasing the percentage of positively stained vs. unstained vessels, the 
protocol could be improved with work pertaining to section integrity, heated antigen 
retrieval, and peroxidase incubation times in order to increase image clarity and stain 
contrast. An example of potentially unstained vessels is shown below, Figure 25. 
One improvement would be optimization of peroxidase incubation times, reduction of 
the temperature for the antigen retrieval, and more tightly controlled heating 
apparatus. Also, the addition of a future counterstain may help improve image quality 
and vessel identification. 
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Figure 25: Example Unstained Vessels. 
40x view (A, B, C) of 2 Week loaded bone. Positively stained vessels are marked 
with black arrows and possible unstained vessels are marked with white arrows  
(A, C). The serial control (no primary antibody) vessels are marked  
with dashed arrows, B. White scale bar is 50 µm. 
 
Aside from the specific Lectin application, the bone-tissue preparation and 
basic procedure enables the protocol and tissues to be utilized for different IHC 
staining and apoptosis staining, with some optimization. The basic IHC protocol can 
accept a different primary antibody other than the Lectin, for labeling other structures.  
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Aim 2: Ischemic Effects on Vascularization and Mechanical Properties. 
Overview 
 Due to the correlation between osteoporosis and PAD, the vascular system 
may play a critical role in the development of these diseases. One way to understand 
and isolate the involvement of the vasculature in bone processes is through induction 
of ischemia. Any resultant remodeling response in bone would most likely be driven 
primarily by the vascular response, as minimal mechanical changes are directly 
induced. Understanding the vascular contribution (and if it is necessary) to bone 
processes and properties is vital to better understand the bone remodeling process and 
osteoporosis implications.  
 
Inducing Ischemia and Physiologic Response 
 From the pulse oximetery data presented in Figure 7, we can conclude that 
ischemia was induced as a result of the surgical procedure. Angiogenesis does occur 
in muscle as a result of the ischemia and hypoxia [15, 29], with vessel density in 
muscle increased at day 7 through day 35 [69]. Additionally, proliferative activity of 
endothelial cells is a maximum at day 7, still increased at day 14, but subsequently 
falls back to control levels by day 21 [69]. In line with these findings, we would have 
expected to see a decreased pulse oximetery in the operated leg up until day 14 but 
the data presented in Figure 8 did not reflect this, most likely due to low instrument 
consistency and accuracy. Ultimately, if the vascular and bone remodeling processes 
are linked, hypoxia and resulting angiogenesis would be the initial processes involved 
in explaining the relationship. Angiogenesis is necessary for bone modeling, so we 
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are testing the hypothesis that independent angiogenesis will be sufficient for bone 
modeling and/or remodeling. We are relying on hypoxia to drive an angiogenic 
response that is independent of mechanical stimulation. 
 
Vascularization in Bone 
 The vascular system is, at the minimum, implicated in the bone modeling and 
remodeling processes, as evidenced by previous work associated with aim 3. In 
response to the induced ischemia there is a marked increase in vascular density in the 
bone by day 14 and that increase from the day 0 and day 7 baseline is sustained until 
day 28, Figure 16. This result points to increased angiogenesis stemming primarily 
from the ischemic condition. In order to support the robust angiogenic response, there 
has to be extensive endothelial proliferation. Some pruning of vessels, or rarefaction, 
may also occur after the initial angiogenic response, evidenced by lack of difference 
between the day 28 operated and unoperated limbs, while the operated limb is still 
greater than day 0 and 7. 
 Since the vasculature is changing, the next step is to determine how this 
change may affect the bone processes. Most often, tissue necrosis occurs to some 
degree in an ischemic environment, necessitating removal and repair of damaged 
tissue. And since the osteoclasts are the cells responsible for tissue removal in bone, 
the vasculature may interact with the osteoclasts in the following way. As previously 
discussed, osteoclast recruitment is tied to the RANK / RANKL complex interaction; 
RANK is an osteoclast membrane receptor and RANKL is the associated ligand 
expressed on endothelial cells and osteoblasts [9]. While poorly understood, it is 
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thought that endothelial cell adhesion, through the RANK complex, relocates the 
osteoclasts from preexisting vasculature into the tissue of interest where they execute 
their function [9]. Thus, increased endothelial cell proliferation could lead to 
increased osteoclast activation and extravasation. Applied to this study, if 
proliferation is occurring between day 7 and 14, osteoclast-enabled tissue removal 
could be occurring during a similar time frame, with removal being the first step in 
the remodeling process after initial hypoxia induced angiogenesis. 
 Confounding these findings is the notion of bone disuse. Due to the surgical 
procedure, the animals tended to favor the un-operated leg, possibly leading to a 
disuse case, leading to bone removal and diminished bone growth [61]. If this is 
occurring, then the necrosis and remodeling bone removal would no longer be the 
sole contributing factor. No study has specifically addressed the vascular implications 
of unloading, but trabecular bone formation and PECAM expression decreased with 
unloading by day 7 and was back to baseline levels after 7 days of normal activity 
[70]. In this case, the vascular implications weren’t directly assessed, as only PCR 
data was used, but as previously described, the PECAM protein could play a role in 
the vascular response including angiogenesis. This finding may support my 
hypothesis as disuse appears to have an inhibitory effect of vascular pathways. 
Conversely, but not directly translatable, increased osteogenesis and angiogenesis 
occur in response to HIF upregulation in defect repair [71], which points to the 
ischemia related response influencing the processes independently. 
 The vascular factor, VEGF, involved in the ischemic response may also have 
substantial effects on osteoclasts, as the osteoclasts express VEGF receptors tied to 
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the RANK complex [35]. VEGF expression is upregulated in bone with exercise, and 
VEGF inhibition prevented bone gain and vascular adaptation in exercising rats [35]. 
Additionally, it is thought that VEGF mediates bone angiogenesis (mirroring its role 
in muscle) and is coupled with increased osteoblast activity during early response to 
exercise [35]. Furthermore, only cells adjacent to capillaries give rise to bone tissue 
and eventual mineralization (because of the RANK / RANKL interactions between 
the osteoblasts, osteoclasts, and endothelial cells), therefore implicating any 
surrounding vasculature in the bone processes [9, 34]. From these findings we can 
deduce that the invading vasculature is a primary factor implicated in the bone 
remodeling processes. 
A higher level discussion of the effect on the processes themselves will come 
in the following section, but as it pertains to this research and sequence of vascular 
and bone processing events, the most significant increase in vasculature occurs at day 
14, prior to any observed mechanical changes. Because of this and for the reasons just 
outlined, it appears that the vascular response is driving the bone remodeling 
response, such that an increase in vasculature, resulting from the ischemia, is directly 
affecting bone cell function. Although similar interpretations have been made for 
bone modeling in fracture repair, this is the first examination of direct ischemia 
effects. 
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Mechanical Property Implications 
 The data presented in Figure 10 lends itself to a variety of conclusions that tie 
nicely into the observed vascular response. Starting with the sham hindlimb, the data 
suggests that there may be bone modeling in the sham tibia by day 7, evidenced by 
the significant increase in stiffness. Furthermore, the data suggest bone removal 
and/or remodeling is occurring in the sham hindlimb by day 28, as the stiffness 
returns to a pre-surgical level. This change can be attributed to increased loading of 
the sham tibia for a week post-operatively, as the animal tends to favor the non-
operated limb, primarily based on every other day observation until the animal was 
not longer ‘limping’. Since bone modeling results from increased loading, the bone 
properties will change, and when the increased stimulus is removed when the animal 
regains normal function, the bone will likely undergo some tissue removal and 
remodeling. 
 For the ischemic hindlimb, it seems that remodeling is occurring in response 
to ischemia, evidenced by the increase in stiffness at day 28 and the trending of the 
ultimate load data. Coupled with the vascular data presented and the possible 
molecular interactions discussed prior, it appears that the ischemia alone is triggering 
the remodeling response, most likely through angiogenesis related processes 
(endothelial cell proliferation, VEGF expression, or both). The emergence of a 
difference in mechanical properties at day 28 fits with the idea of vascular changes 
driving remodeling changes.  
Remodeling results in an increased mineralization of the bone tissue changing the 
mechanical properties [55]. Most notably, an increase in mineralization, and resulting 
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increase in stiffness, enhances the brittle nature of the bone leading to an increased 
susceptibility to microcracks or whole bone fractures [55]. Because there is an 
increase in stiffness at day 28, we can conclude that remodeling may be transpiring. 
We hypothesize that the following is resulting from the ischemia and influencing 
bone remodeling:  
1. Ischemia is induced with resulting hypoxia and tissue necrosis 
2. Osteoclast recruitment closely follows the resulting angiogenic response 
through RANK/ VEGF interactions 
3. Tissue removal occurs between day 7 and day 14 (commencing the 
remodeling process) as vasculature advances 
4. Remodeling process proceeds and systemic changes are observed by day 28 
 
From this hypothesis it appears that the bone remodeling process can be 
stimulated solely by a vascular response to ischemia. Previous work seems to support 
facets of this finding and help explain how these interpretations were made. In 
patients with PAD, where tissue necrosis is increased, there is a reduction in nutrient 
supply which impairs the bone repair process, which points to the necessity of a 
vascular response [3]. There is also a decrease in bone formation attributed to 
ischemia at day 10 and 14, again indirectly implicating the vascular system with bone 
processes [72]. In regards to time scale, in humans it takes 20 days for initiation and 
tissue removal by osteoclasts prior to any bone formation occurring in a specified 2 
dimensional plane [61], and although not specifically defined, due to the similarity 
between BMUs in mice and humans, we may be able to assume the removal 
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timescale in mice is similar. This removal time scale fits well with the hypothesis, as 
remodeling processes may be occurring by day 28. The hypothesis outlining the 
possible interaction between the vascular and bone processes is highly relatable to 
osteoporosis treatment, and will be discussed later, especially in understanding 
disease onset in patients with osteoporosis and PAD. 
 With osteoporosis, the patient has lower BMD and stiffer bones (tied to the 
brittleness of the tissue). If tissue necrosis occurs, the vasculature and osteoclasts will 
respond. This will lead to even more bone resorption and greater risk to the patient. In 
a patient with PAD, however, the result may be more critical. With PAD, a greater 
amount of necrosis may occur and the vascular response will most likely be 
diminished due to the disease pathogenesis. This may be problematic as the response 
to tissue hypoxia will still result in VEGF expression, effectively recruiting more 
osteoclasts. And without the vasculature in place to allow for the full remodeling and 
bone deposition process, the bone tissue will necrose and be resorbed, amplifying the 
osteoporotic condition. This hypothesis may explain the connection between PAD 
and osteoporosis. 
It is known than the vasculature is required for bone remodeling, but the 
seemingly direct connection of the ischemic environment to stimulated remodeling is 
a novel observation. Furthermore, it appears that angiogenesis is sufficient for bone 
remodeling and this ischemic influence on bone remodeling could further our 
understanding of the system interactions. Thus, the stimulation of angiogenesis alone 
could have an effect on bone, in the long term. There would likely be a period of 
damaged (microcrack or necrosis) tissue removal, but over time, the angiogenic 
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response would provide the framework for bone growth and repair. In this capacity, 
stimulating angiogenesis could provide new treatment strategies for patients with both 
PAD and osteoporosis. 
 
Future Work 
 Continuation of this research should involve quantification of any occurring 
remodeling, so that the proposed hypothesis would be better supported. Additional 
experiments involving isolated, non-exercising post-operational recovery could also 
be performed to further isolate the ischemic response. To determine the role of disuse, 
an array of treatments could be applied. One treatment could look at disuse and 
ischemia vs. disuse control and other would be observing disuse in the short term for 
both hindlimbs, followed by normal use. Disuse could be accomplished by nerve 
crushing or tail suspension. These varying treatments would reveal contributions of 
the disuse mechanism, as well and furthering the ischemic coupled bone remodeling 
hypothesis. 
 Validation of the time course and possible causal relationship of the 
vasculature to remodeling could also be performed. Angiogenesis could be stimulated 
at particular intervals and for varying durations in order to reveal the time course for 
any resultant bone remodeling. One angiogenesis stimulant could be a HIF gene 
therapy. Upregulation of HIF, and use of bone marrow-derived mesenchymal stem 
cells (BSMCs), and increased osteogenesis and angiogenesis in defect repair have 
been detailed in previous studies [71]. By directly inducing an angiogenic response, 
the bone remodeling response could be defined as a function of both time and 
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stimulation amplitude. Some of these experimental treatments could translate into the 
clinical realm. 
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Aim 3: Vascularization in Response to Induced Remodeling 
Overview 
Bone remodeling and the BMU are highly implicated in the development of 
osteoporosis [34, 39]. Additionally, the microvasculature is critical in the bone 
remodeling process [9], but the degree to which vasculature is involved in 
osteoporotic onset is not well defined. Establishing the vascular contribution to the 
remodeling process may reveal treatment opportunities for remodeling-dependent 
pathologies such as osteoporosis. 
 
Previous Research Comparison 
Although not specifically quantified, prior studies indicated that a majority of 
the increases in vascularization occurred in the periosteal region [52], however this 
study shows no such findings. Additionally, at day 14, and at a similar strain value, 
previously quantified increases in vessel number were around 200% [52], compared 
to 70% increase in vessel density seen in this study. Several factors, including 
methodology and analysis, may explain this discrepancy. As previously mentioned, 
the IHC most likely stained less vessels than were actually present in the tissue, 
compared to other published vascular data [52], and despite a significant result 
presented in this paper, it was not as robust as previous findings. Due to the IHC 
resolution issues, data was presented as vessel density, opposed to total vessel number 
or percent change from day 0, which may shield additional similarities between the 
two studies. 
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Vascularization in Response to Induced Remodeling 
 Based on the objective, the results support the observation of an increase in 
vasculature from induced mechanical loading. This occurrence was only seen in the 
day 14 loaded animals and not in the day 35 animals. A similar result has been shown 
previously, vessel size and number increases with mechanical loading at day 14 [52], 
and can be explained by osteocyte responses. Fluid shear and tissue strain increases 
due to the load, triggering the Wnt signaling pathway leading to osteogenesis [68]. As 
previously established, vasculature is required for bone formation, thus an increase in 
vasculature is seen by day 14 in order for bone formation to occur. However, the 
initial stimulus, rather than the long-term stimulus, has a greater impact on bone 
formation [61], which can explain the vessel density disparity at the day 35 time point 
compared to day 14. A reasonable explanation for the dependence of bone formation 
on initial loading stimulus, and why changes are observed at two weeks and not at 
five weeks, are 'desensitization' of bone cells occurring with increased loading 
durations, evidenced by a bone formation plateau [61]. Through cytoskeletal 
reorganization within the osteocyte due to routine loading, the mechanosensitivity 
and activation threshold is altered, resulting in diminished bone formation and 
remodeling over time [61]. If there is a correlation between vascularization and bone 
formation/ remodeling, Figure 20 would support the desensitization hypothesis. It is 
also possible that by day 35, some pre-study existing bone is no longer utilized (due 
to the change in applied load), leading to its removal, along with any associated 
vasculature [61]. This hypothesis is supported by the decrease of vessel density in the 
day 35 time point compared to day 14. However, without directly quantifying the 
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amount of remodeling that is occurring over time, it is hard to speculate on what the 
changes in vascular density are supporting; whether it’s modeling and maintenance or 
the remodeling process. 
 Examining vascular density changes from a more specific view, regional 
analysis revealed an increased vessel density in the lateral region and may be 
described by increased load and decreased sclerostin in the region of formation. 
Sclerostin is a molecule normally secreted by osteocytes in a homeostatic 
environment and acts to suppress the osteogenic response. However, strain suppresses 
production of sclerostin, leading to increased bone formation through the 
diminishment of osteogenic regulation [68]. In the tibial loading model, some of the 
highest compressive stain is seen in lateral region [68, 73], stimulating bone growth 
in that area, with previous research showing increased matrix mineralization in the 
lateral region in response to mechanical loading [68]. And consistent with prior 
conclusions, these changes are only observed at the 2 week loading time point. In 
both of these scenarios, vascularization is necessary in order for the osteogenic 
process to occur, thus increased levels of vessel density are seen in the lateral region 
of the loaded tibias. 
 Understanding of induced bone modeling and remodeling has accompanied 
observations regarding bone vasculature. Bone modeling appears to occur in the sub-
periosteal region with mechanical loading [53], so one can hypothesize that if 
remodeling is occurring, it would arise in the cortical bone. Because the main 
mechanical stimulus for remodeling is changing strain and microdamage, this can 
only occur in fully mature bone, which in this experimental case, only exists in the 
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cortical region. With this assumption, and the fact that vasculature is required for 
bone remodeling, the increase in cortical vessel density at 2 weeks appears to be 
indicative of remodeling events. If that is indeed the case, it seems that the apparent 
remodeling profile is time and location dependent. Extrapolating to osteoporosis, if 
the vasculature is intimately involved with the normal remodeling response, this 
interaction and time dependence could be targeted as a possible treatment target or 
diagnostic; for example, using contrast CT to quantify vascularization in the bone 
tissue to draw conclusions about the bone tissue health (necrosis, density). 
 As the most basic conclusion from this study, we can interpret the data as 
vascularization being concurrently implicated in the bone response to mechanical 
loading. And since we know that modeling (in response to the applied loads and 
resultant strain changes) and remodeling (in response to induced microdamage and 
subsequent repair) occurs in response to loading, we can conclude that the 
vascularization is concurrently implicated in the remodeling and modeling of bone. 
Moving forward from this study, we know that vascularization is necessary for bone 
remodeling [9], and based on the presented data, vascularization seems to be 
stimulated by mechanical loading in areas of preexisting bone. Since vascular growth 
precedes remodeling and bone formation, these findings can be applied as a treatment 
for osteoporotic patients; as it appears that loading can provide stimulation for 
increased vascularization in preexisting bone, hopefully resulting in bone growth 
and/or remodeling. One way to accomplish mechanical stimulation is using vibration, 
which has shown increased bone mass [74]. Although the effect of loading has been 
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proven helpful [74], our data suggest that the positive remodeling effect can be 
increased and modulated by loading duration and frequency. 
 
Future work 
 It needs to been seen whether the observed increase in vasculature is 
correlated to increased bone remodeling. Quantification of the integrity of osteocytes, 
with an apoptosis stain, both regionally and between cortical and periosteal tissue, 
will lead to more robust interpretations and understanding of the interaction between 
the vasculature and bone remodeling. Similarly, a model of short-term loading cycle 
and lengthened recovery along with remodeling analysis might elucidate the sequence 
between bone formation and loading stimulus. If a sequence is fully defined, we can 
then interpret the findings as a causal relationship between the vascular and bone 
systems. Furthermore, quantification of skeletally mature (6 month) C57 day 0 
animals could lead to more definitive conclusions regarding time dependence. 
 C57 mice are more sensitive than most animals to mechanical loads, including 
more bone gain per unit of strain [75], so future experiments involving other animal 
models may more closely simulate the human physiologic response. Additionally, 
experiments examining only vascular gain of function treatments would be beneficial 
to observe if a mechanical stimulus is required for bone remodeling, or if only a 
purely vascular stimulus will result in bone formation and remodeling. For this type 
of study, all involved cells (osteoclasts, osteoblasts and osteocytes) as well as 
osteocyte apoptosis would need to be quantified in order to determine the amount of 
remodeling. Associated findings would be directly relatable to the treatment of 
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osteoporosis as modulation of the bone remodeling process is the key component of 
the disease. 
 
Final Thoughts 
 We have shown the concurrence and causal relationship of the vasculature to 
the bone remodeling process and have furthered our understanding of the seemingly 
intimate interaction of the two physiologic systems. These findings could be 
especially helpful in new treatment strategies that mainly target the vascular system 
or that incorporate the interaction of the two systems. There are some emerging 
treatments that can benefit from increased understanding.  
Vitamin D administration has seen positive results for patients with both PAD 
and osteoporosis, as vitamin D increases BMD in osteoporotic patients with PAD and 
alleviates symptoms associated with lack of vitamin D, including bone aches, pain, 
and weakness [51]. Prolyl hydroxylase (PHD) inhibitors increase angiogenesis and 
could increase capacity for bone regeneration if used in osteoporotic patients [57]. 
Exercise and low level vibration can increase bone formation, decrease bone 
resorption, raise peak bone mass, and enhance bone strength, and may be able to be 
used concurrently with a vascular treatment to improve efficacy [74]. Also, with 
bisphosphonates (BP) treatment, osteoprotegerin (OPG) is positively correlated with 
BMD [76], which is to be expected because OPG regulates the osteoclasts and may 
have an effect on osteoblasts. 
 By taking into account the vascular and bone systems, the application of this 
study could be instrumental in further research and clinical application. 
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APPENDIX A: PROTOCOLS 
 
Hindlimb Ischemia Surgery - Resection 
 
Mouse Information 
DOB: ____________________________  
Sex: ____________________________  
Tag:  
Genotype/strain: ___________________  
Cage: ____________________________  
 
Materials 
Autoclave in Surgical Instrument Container 
____1. Standard pattern forceps (1) 
____2. S&T forceps (2) 
____3. 5-45 forceps (1) 
____4. Iris scissors (1) 
____5. Microdissection scissors (1) 
____6. Castroviejo (1) 
____7. Retractor (1) 
 
Autoclave in Surgical Pack 
____8. 4 x 4 gauze sponge (3) 
____9. cotton swabs (12) 
____10. 6.0 silk suture (2 x 1-inch) 
____11. Surgical drape (1) 
 
Obtained in surgery suite 
____12. sterile Petri dish w/ sterile saline 
____13. sterile gloves 
____14. sterile 7.0 prolene suture 
____15. heat-cautery 
____16. FST heat pad w/ rectal probe 
____17. Recovery heat pad 
____18. recovery bin & weigh boat 
____19. depilatory cream 
____20. non-sterile cotton swabs 
____21. non-sterile 2 x2 gauze sponge 
____22. isolation mask & cap 
____23. analgesic (Buprenorphine) 
 
Surgery preparation 
____24. Spray surgery area with Nolvasan 
____25. Weigh animal in weight boat 
____26. Place animal in anesthesia box 
____27. Open the oxygen cylinder and set 
anesthesia-machine flow meter to ~3 
l·min-1 
____28. Anesthetize animal w/ 5% isoflurane  
____29. Reduce flow rate to 0.5-1.0 l·min-1 and 
the isoflurane to 1-3% 
____30. Apply ear tag high on left ear 
____31. Lay animal supine with nose in nose-
cone 
____32. Shave hair on the right and left hindlimb 
& lower abdomen with clippers  
____33. Remove excess hair with depilatory 
cream 
____34. Spray right and left hindlimb with 
Nolvasan 
____35. Return animal to anesthesia box 
 
____36. Lay animal supine on circulating heat pad w/ 
nose in nose-cone 
____37. Insert rectal probe and set thermo-controller 
to 35°C 
____38. Apply veterinary ointment to eyes to avoid 
drying during procedure 
 
Surgery 
____39. Make a small incision on the middle, medial 
aspect of the left thigh 
____40. Extend the incision up to the abdominal wall  
____41. Blunt dissect the subcutaneous connective 
tissue to maximize surgical exposure 
____42. Use cautery to remove fat pad overlying 
femoral a-v pair & cauterize epigastric a-v 
pair 
____43. Blunt dissect the femoral artery-vein pair 
from the nerve starting just upstream to the 
muscular branch & extending to half-way 
between the knee & ankle 
____44. Tie off the saphenous a-v pair with 6.0 silk 
suture, halfway between the knee & ankle 
____45. Tie off the femoral a-v pair with 6.0 silk 
suture, halfway just upstream to the muscular 
branch 
____46. Grasping the distal ligature, use the cautery & 
microscissors to remove the a-v pair up to the 
upstream ligature 
____47. Gently rest cotton swabs on hemorrhage sites 
____48. Use 6.0 polypropylene suture to close the 
skin  
____49. Make a small incision on the middle, medial 
aspect of the right thigh 
____50. Extend the incision up to the abdominal wall  
____51. Blunt dissect the subcutaneous connective 
tissue to maximize surgical exposure 
____52. Use 6.0 polypropylene suture to close the 
skin  
 
Post-Surgical  
____53. Give the animal an subcutaneous injection of 
buprenorphine (0.075mg/kg) 
____54. Place the animal in the recovery bin, on a 
blue bench cover, above a heat pad and allow 
to recover 
____55. Turn flow meter down to 0, turn off 
isoflurane, and close the oxygen cylinder 
____56. Indicate surgery on cage card  
 
Notes 
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
_________________________________________________________
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Figure 26: Surgical station with instruments. 
Key components are labeled and indicated with arrows. 
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Tibial Dissection – Mechanical Testing 
 
Mouse Information 
DOB: _____________________  
Sex:_______________________   
Tag: ______________________  
Genotype/strain: _____________  
Cage: _____________________  
 
Materials 
____57. Standard pattern forceps 
____58. S&T forceps 
____59. Iris scissors 
____60. Microdissection scissors  
____61. Bone scissors 
 
____62. Kimwipes (2) 
____63. Centrifuge vials (2) 
____64. Tape 
 
Dissection preparation 
____65. Place animal in anesthesia box 
____66. Open the oxygen cylinder and set anesthesia-machine flow meter to ~3 ml·min-1 
____67. Anesthetize animal w/ 3% isoflurane  
____68. Perform cervical dislocation on animal to euthanize 
____69. Lay animal supine and tape forepaws down 
 
Dissection 
____70. Make a small incision on the middle, medial aspect of the left thigh 
____71. Extend the incision up to the proximal head of the femur and down to the ankle 
____72. Blunt dissect the subcutaneous connective tissue and remove the skin around the 
hindlimb 
____73. Using the microdissection scissors, cut the tendons and ligaments at the ankle joint 
including the Achilles 
____74. Sever the patellar tendon with the microdissection scissors 
____75. Peel off all surrounding musculature from tibia and fibula 
____76. Using the bone scissors, cut at the knee and ankle joints to separate the tibia/fibula 
____77. Remove the fibula using the bone scissors 
____78. Wipe off any remaining tissue from the tibia using the Kimwipe 
____79. Place the excised tibia in a properly labeled vial 
____80. Repeat process for right hindlimb 
 
Post-Dissection 
____81. Record animal usage in the log 
____82. Place the animal in the in a sealed plastic bag and then into the biohazard bag 
____83. Put the vials (containing the tibae) into the freezer 
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Tibial Dissection – Histology 
 
Mouse Information 
DOB: _____________________  
Sex:_______________________   
Tag: ______________________  
Genotype/strain: _____________  
Cage: _____________________  
 
Materials 
____84. Standard pattern forceps 
____85. S&T forceps 
____86. Iris scissors 
____87. Microdissection scissors  
____88. Bone scissors 
 
____89. Kimwipes (2) 
____90. Centrifuge vials (2) 
____91. Tape 
 
Dissection preparation 
____92. Place animal in anesthesia box 
____93. Open the oxygen cylinder and set anesthesia-machine flow meter to ~3 ml·min-1 
____94. Anesthetize animal w/ 3% isoflurane  
____95. Perform cervical dislocation on animal to euthanize 
____96. Lay animal supine and tape forepaws down 
 
Dissection 
____97. Make a small incision on the middle, medial aspect of the left thigh 
____98. Extend the incision up to the proximal head of the femur and down to the ankle 
____99. Blunt dissect the subcutaneous connective tissue and remove the skin around the 
hindlimb 
____100. Using the microdissection scissors, cut the Achilles tendon 
____101. Sever the patellar tendon with the microdissection scissors 
____102. Peel off the gastrocnemius muscle 
____103. Using the bone scissors, cut at the knee and ankle joints to separate the tibia/fibula 
____104. Place the excised tibia in a properly labeled vial 
____105. Repeat process for right hindlimb 
 
Post-Dissection 
____106. Record animal usage in the log 
____107. Place the animal in the in a sealed plastic bag and then into the biohazard bag 
____108. Fill vials (containing the tibae) with Histachoice 
____109. Store vials at room temperature and in an appropriate location 
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Immunohistochemistry 
Endothelial Cell Marker Lectin Checklist: Paraffin Embedded Sections 
 
Incubation 
Time 
Reagent 
10 min Oven at 80 C (setting 7) after sections mounted on slides 
10 min Xylene 
3 min 100% EtOH 
3 min 100% EtOH 
3 min 95% EtOH 
3 min 85% EtOH 
3 min 70% EtOH 
3 min 50% EtOH   
5 min Distilled Water   
Antigen 
Retreival 
Rice cooker at 95 C for 10 min (samples in Citrate Buffer)  
10 min D-PBS pH 7.4   
60 min RT° 1° Lectin GS1  in D-PBS               
      Use .1 ml Lectin  and 4.9 ml PBS (10 ug/ml) 
30 min, RT 2° Streptavadin   Use Vector AB Kit :2.5ml PBS, 1 Drop A and 
Mix, 1 Drop B and Mix 
3 min D-PBS pH 7.4   
15 min DAB Substrate – when light brown color is observed put in 
ddH2O 
 
3 min Distilled Water  
10 seconds 95% EtOH  
10 seconds 100% EtOH  
30  seconds Xylene  
 Xylene + permount  
   
 
 
 
 
 
Study                                         . 
Staining performed by                        
Date           /         /            
 
 
 
 
Associated protocol description and notes 
After sectioning, place the slides in the tray and place the tray in the oven in 
the orientation shown in Figure 31 to ensure tissue attachment on the edges of the 
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slides. Additionally, 10 minutes is an estimate, leave in the oven until the slides are 
translucent, at which time place immediately into the xylene. 
 
 
Figure 27: Slide tray placement in the oven. 
Tray is indicated by white arrow. 
 
 The xylene and ethanol hydration steps should be performed in the hood and 
in the solution dishes. Place and remove the slide tray from dish to dish slowly and 
gently to avoid tissue detachment. Illustration of a dish with the slide tray and the 
array of dishes are shown below in Figure 32. 
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Figure 28: Dish array and dish with slide tray. 
 
 During hydration steps, fill the rice cooker pot 1/3 with water, turn on the rice 
cooker to the ‘Cook” position, and place a dish with citrate buffer in the cooker. 
Cover the pot and periodically check the temperature with the thermometer until 95º 
C is reached. For the antigen retrieval step, place the slide tray and thermometer in 
the hot citrate buffer dish and replace the lid. The proper arrangement is illustrated in 
Figure 33. Monitor the temperature and remove the lid for several seconds at a time 
if the temperature is too high. 
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Figure 29: Antigen retrieval set up. 
Dish and thermometer is visible, with the ‘Cook’ light illuminated. 
 
 After the 10 minutes remove the slide dish and unplug the rice cooker. With 
the hydrophobic pen, outline the tissues from each section to isolate them. Figure 34 
below illustrates this technique. 
 
 
Figure 30: Hydrophobic tissue outline 
Blue circles represent the tissue, and the dashed lines represent the  
hydrophobic pen outline. 
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 After tissue outlining, place the slides into the paper towel lined incubation 
Tupperware. Pipette the reagents, using the 1 ml pipette, onto the tissue, within the 
hydrophobic outline. An example of incubating slides is shown in Figures 35 below. 
 
 
 
Figure 31: Slides with reagent applied. 
Top image, Lectin incubation. Bottom image, DAB incubation, with pipette visible. 
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 To remove the reagents, use the vacuum shown in Figure 36. Following all 
reagent incubations, remove the any residual fluid before putting the slides back into 
the tray. After all slides have been subject to 30 of xylene, take the slides out one at a 
time and immediately apply mounting medium and coverslip. To prevent tissue 
detachment, apply the mounting medium directly on top of the tissue. Let slides dry 
overnight. The final step is shown in Figure 37 below 
 
 
Figure 32: Reagent removal with vacuum. 
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Figure 33: Completed slides. 
Key components are labeled and indicated with arrows. 
 
99 
APPENDIX B: APPARATUS AND EQUIPMENT FIGURES 
 
 
Figure 34: Overview of the 3 Point Bending apparatus. 
Key components are labeled and indicated by arrows. 
 
 
Figure 35: Zoom view of bending apparatus.  
Bone tray, load cell and point of contact are visible.  
Arrow indicates location of tibia. 
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Figure 36: Overview of the cortical thickness measurement apparatus  
Key components are labeled and indicated with arrow.  
 
 
Figure 37:Pulse oximeter device. 
Hindpaw measurement cuff indicated with arrow 
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APPENDIX C: ADDITIONAL DATA 
 
 
 
 
 
Day Ultimate Stress (MPa) Elastic Modulus (Gpa) 
 
Sham Resection Sham Resection 
28 282.4 ± 30.6 371.8 ± 77.5 4.4 ± .5 6.1 ± 1.5 
14 276.0 ± 22.6 251.8 ± 28.9 4.2 ± .4 3.7 ± .5 
7 265.1 ± 5.7 247.2 ± 51.4 3.9 ± .1 3.7 ± .9 
0 218.6 ± 12.0 265.1 ± 24.6 3.2 ± .2 4.0 ± .5 
